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ABSTRACT 
The hazardous technique of endoscopic manometry precludes the 
investigation of "normal volunteers" required to advance our knowledge 
of the physiology and pathophysiology of the sphincter of Oddi, a 
suitable animal model is required. Large and small animal models have 
been proposed, as yet no one model has been accepted as being 
representative of the human sphincter of Oddi. Furthermore no animal 
model of sphincter of Oddi dysfunction has been developed. 
In this thesis a porcine animal model of sphincter of Oddi function has 
been developed. The importance of selecting the appropriate 
anaesthetic agent, enflurane, has been proven. The effect of 
cholecystectomy on the porcine sphincter of Oddi is shown to have no 
overall significant effect on sphincter motility when compared to a sham 
laparotomy group. However, two of the seven pigs after 
cholecystectomy showed a paradoxical rise in sphincter basal pressure 
after cholecystokinin infusion, these animal may represent porcine 
sphincter of Oddi dysfunction. 
Although substance P is found throughout the intestinal tract including 
the sphincter of Oddi of man and pig its action was hitherto unknown. 
In this thesis exogenous substance P was shown to stimulate the 
sphincter of Oddi in vivo. 
In this thesis the first development in sphincter of Oddi manometry 
catheter design in nearly twenty years is presented. A superior nine 
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lumen catheter has been evaluated in porcine model and subsequently 
used to assess sphincter of Oddi asymmetry in man. 
Two retrospective studies are reported in this thesis; an audit of the 
largest U. K. series, and a study assessing the relationship of sphincter 
of Oddi motility and duodenal activity. Tachyoddia dissociated from the 
duodenal migrating motor complex was associated with a raised 
sphincter of Oddi basal pressure and may be a part of sphincter of 
Oddi dysfunction. 
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INTRODUCTION 
1.1 Historical Aspects 
Francis Glisson was the first to describe the sphincter choledocus in 
1681 (Hendrickson 1989, Van Gulik 1990). However this sphincteric 
muscle was later named in 1887 after the Italian physiologist Dr. 
Ruggero Oddi who was the first to demonstrate its presence in several 
animals and to measure and document its action, to resist bile outflow 
from the bile duct into the duodenum. 
1.2 THE SPHINCTER OF ODDI IN MAN 
1.2.1 Embryology 
The liver begins its development during the third week of gestation as 
an outgrowth of the endodermal epithelium at the distal end of the 
foregut. It is initially known as the liver bud or hepatic diverticulum. 
The common bile duct develops by the narrowing of the connection 
between the foregut and the liver bud. The gallbladder and cystic ducts 
develop as outgrowths from the ventral aspect of the bile duct. 
The pancreas starts to develop at about day 30 as two endodermal 
buds on from the dorsal mesentery, the dorsal pancreatic bud, and one 
close to the bile duct the ventral pancreatic bud. The duodenum 
20 
rotates to become C-shaped and at this time the ventral pancreatic 
bud migrates dorsally and finally the ventral bud comes to lie 
immediately below and behind the dorsal bud. During the sixth week of 
development the dorsal and ventral parts fuse. The ventral bud forms 
the uncinate process and the inferior part of the head of the pancreas. 
The remaining part of the gland is derived from the dorsal bud. The 
main pancreatic duct (of Wirsung) forms from the distal part of the 
dorsal pancreatic duct and the entire ventral pancreatic duct. The 
proximal part of the dorsal pancreatic duct forms the accessory duct 
(of Santorini). 
The sphincter of Oddi is formed at the site where the bile duct and 
pancreatic ducts enter the duodenal wall. 
1.2.2 Anatomy 
The biliary and main pancreatic ducts enter the duodenum at the 
Ampulla of Vater located in the second part of the duodenum in man. 
At autopsy the three commonest anatomical variations of the ampulla of 
Vater are (Plate A), the Y-shaped orifice (61.2%) with the pancreatic 
and bile ducts joining to form a long common channel ending in a 
single orifice, the U-shaped where the pancreatic and bile ducts remain 
separate with separate orifices (22.4%) and the V-shaped (14.3%) with 
a short common channel (Flati et al 1994). There are three distinct 
areas of muscle thickening; the sphincter choledochus 
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Plate A: schematic presentation of the anatomical variations found 
in the Ampulla of Vater (Morganroth et al 1991) 
A: The V-shaped orifice neighboring ducts joining to form a short 
common channel 
B: The U-shaped orifice with the ducts remaining separate. 
C: The Y-shaped orifice with the neighboring ducts forming a 
longer common channel. 
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around the common bile duct, sphincter pancreaticus around the 
pancreatic duct, and sphincter ampullae around the Ampulla of Vater 
together these constitute the sphincter of Oddi. 
When there is incomplete fusion of the dorsal and ventral ducts during 
development, the main pancreatic duct develops from the whole of the 
dorsal duct and drains into the duodenum via the accessory sphincter, 
this is known as pancreas divisum. This is the most common 
congenital abnormality and has been reported in 3.4-12.9% of patients 
undergoing endoscopic retrograde pancreatography (Gregg 1977, 
Mitchell et al 1979, Cotton 1980 and Bernard et al 1990). However as 
these patients represent a selective group, the true incidence in the 
population not undergoing any upper, abdominal investigation is 
unknown. 
1.2.3 Neuro-humoral control 
The biliary tract is subject to both neuronal and hormonal control. The 
latter predominates in most species. More is known about the hormonal 
control of the sphincter of Oddi especially in animals, but our 
knowledge is far from complete in man. 
Cholecystokinin appears to be the most important hormone regulating 
sphincter of Oddi and gallbladder function. The action of cholecystokinin 
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differentiates species into two groups, type 1: species with a pump like 
sphincter of Oddi which show increased activity to expel bile in 
response to cholecystokinin and type 2: species with a resistor like 
sphincter of Oddi which relax in response to cholecystokinin allowing 
bile flow. Historically authors disagreed on the action of cholecystokinin 
in man (fig. 1), however it is now taken that its action is to relax the 
sphincter (Toouli et al 1982, Tokunaga et al 1993). 
The gallbladder and sphincter of Oddi are parasympathetically 
innervated by the vagus nerve, sympathetic innervation originates in the 
coeliac ganglion and spinal routes T7 to T10 (Becker et al 1993, 
Becker 1993). Evidence, based on animal studies in the Australian 
possum (Takahashi et al 1988) (a type 1, pump-like sphincter), has 
shown that vagotomy does not alter resting activity or the 
synchronization of sphincter phasic activity with the duodenal migrating 
motor complex. Vagotomy does lead to an alteration in the response to 
a meal, with a resulting reduction in sphincter of Oddi spike activity 
and diminished gallbladder emptying in the possum. Vagotomy also 
results in a more marked response to intravenous cholecystokinin- 
octapeptide and motilin. 
There is also evidence that the right and left thoracic branches of the 
vagus may have differing actions (Funch-Jensen et al 1981). Funch- 
Jensen found that in dogs electrostimulation of the right and left 
branches of the thoracic vagus increased bile flow, by relaxing the 
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sphincter of Oddi and contracting the gallbladder. Stimulation of the 
right vagus alone produced a more complex response, the initial 
inhibition of the sphincter of Oddi was followed by an increase in 
motor activity. Although animals studies suggest an important role for 
the vagus in sphincter control the action of the vagus in man has not 
been fully elucidated. 
Sympathetic innervation originates in the coeliac ganglion and spinal 
routes T7 to T10 (Becker et at 1993). Noradrenaline acts on pre and 
postsynaptic receptors as an inhibitory neurotransmitter in the guinea-pig 
sphincter of Oddi. The action in man is again unknown. 
Alterations in gallbladder or duodenal distension lead to changes in 
sphincter of Oddi motility thus suggesting that direct local neural 
connections between the gallbladder, sphincter of Oddi and duodenum 
may exist (Saccone et al 1994, Simula et al 1997). Electrical 
stimulation of the duodenal ampulla provokes gallbladder contraction 
and this effect can be abolished by transection of the bile duct (Becker 
et al 1993). 
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Fig. 1 The action of Intestinal Hormones on the Sphincter of Oddi 
(Sarles 1986) 
Animal CCK Gastrin Cerulin Secretin Glucagon 
Rabbit 
In vivo 0 .L 
In vitro % -- % -- -- 
Dog 
In vivo T or ,G T or ,l -- .L "ý In vitro -- -- -- -- -- 
Cat 
In vivo 1 -- -- -- 
In Vitro 1 -- -- -- -- 
Guinea pig 
In vivo .L -- I -- 
In Vitro 0 -- I -- -- 
Opossum 
In vivo T % ,G0 .G or 0 
Man Tor I% or IIPl or o 
Key :T contraction of the sphincter of Oddi 
.G relaxation of the sphincter of Oddi 
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FIG. 2 IMMUNOREACTIVITY OBSERVED IN SMOOTH MUSCLE 
LAYER OF SPHINCTER OF ODDI IN SUBJECTS WITH NO 
PANCREATOBILIARY DISEASES AND IN PATIENTS WITH 
GALLSTONE DISEASE. PANCREATITIS. OR PERIAMPULLARY 
CARCINOMA (SAND ET AL 1994) 
No Pancreatobiliary 
diseases 
Organ Autopsies 
donors 
(n=5) (n=3) 
Gallstone 
disease 
(n=5) 
Pancreatitis 
Periampullary without 
Carcinoma gallstones 
(n=3) (n=3) 
VIP ++ + + + 
PHI ++ + + + 
NPY ++ + + + 
Somatostatin ++ + + + 
CGRP ++ + + + 
Galanin ++ + + + 
SubP ++ + + + 
Enkephalin ++ + + + 
Bombesin -- - - - 
Key immunoreactivity observed 
-, no immunoreactivity observed. 
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Anatomical evidence of direct pathways between the gallbladder and 
duodenum and the gallbladder and the sphincter of Oddi have been 
shown using retrograde labeling (Mawe et al 1997). 
Immunohistochemical studies have located neural networks connecting 
the duodenum with the gallbladder and the sphincter of Oddi, and the 
sphincter of Oddi with the gallbladder (Padbury et al 1993, Simula et al 
1997, Simula et al 1997). This implies that enteric nerve circuits 
participate in coordinating duodenal and biliary functions. 
Many peptide neurotransmitters have been elucidated on 
immunohistochemical staining of the sphincter of Oddi (fig 2), however 
their action is unknown. Recently the non-adrenergic-non cholinergic 
transmitter, nitric oxide has been a source of much interest (Allescher 
et al 1993, Kaufman et al 1993, Baker et al 1993, Mourelle et al 
1993, Manci et al 1995, Thune et at 1995, Konturek et at 1995, 
Altdorfer et al 1996, Sand et al 1997 and Shima et al 1998). The 
sphincter of Oddi in both pigs and humans have endogenous nitric 
oxide synthatase activity and immunoreativity. Inhibition of endogenous 
nitric oxide production, enhances contractility while exogenous nitric 
oxide decreases sphincter contractility and electrical activity (Sand et al 
1997). In view of this effect, glycerl-trinitrate has been used as a nitric 
oxide donor to aid cannulation of the biliary ampulla at endoscopic 
retrograde cholangiography (Luman et al 1997) and has also been 
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suggested as a therapeutic option in the treatment of sphincter 
dyskinesia (Staritz et al 1985 and Velosy et al 1997). 
1.2.4 Function 
The role of the sphincter of Oddi is to regulate the flow of bile and 
pancreatic juice into the duodenum. 
Bile is produced by the liver and is an isotonic aqueous mixture 
consisting mainly of electrolytes, proteins, bile salts, cholesterol, 
phospholipids, and bilirubin. Secretion across the canalicular membrane 
of the hepatocyte accounts for about two thirds of total bile flow. The 
remaining one third is an alkaline fraction generated by the epithelial 
cells lining the bile ducts. The total volume of bile produced daily is 
between 500 and 800mis. During the fasting phase bile is stored in 
the gallbladder, with a capacity of 60 millilitres. The gallbladder also 
acts to concentrate bile salts by the rapid and selective absorption of 
fluid and electrolytes. The average bile salt content is a mixture of 
chendodeoxycholate, cholate, deoxycholate, ursodexoycholate and 
lithocholate. Bile salts aid fat absorption in the small intestine by 
forming micelles. 95% of bile salts are reabsorbed throughout the 
intestine, bound to albumin in the portal blood and then removed by 
hepatocytes, this constitutes the enterohepatic circulation. 
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The sphincter of Oddi in man acts as a resistor to bile flow and 
assists in the collection of bile in the gallbladder and also prevents the 
reflux of duodenal contents into the biliary pancreatic ducts. In 
response to a meal, a combination of parasympathetic innervation via 
the vagus nerve and the humoral effect cholecystokinin leads to 
contraction of the gallbladder and relaxation of the sphincter of Oddi 
occurs, propelling bile into the duodenum. 
1.3 SPHINCTER OF ODDI DYSFUNCTION 
1.3.1 Background 
It was Dr. Ruggerio Oddi himself who first recognized that the 
sphincter of Oddi might be responsible for clinical problems "It is 
possible that the sphincteric function of the distal choledochal 
musculature explains some clinical problems that are still 
obscure.... '. (Oddi 1887). To this day the clinical syndrome remains 
poorly defined, incompletely understood and difficult to diagnose. 
A number of terms have been used to describe the same clinical entity 
e. g. papillary stenosis, sclerosing papillitis, biliary spasms, biliary 
dyskinesia and postcholesyctectomy syndrome. Sphincter of Oddi 
dysfunction is now regarded as falling into two types, sphincter of 
Oddi stenosis; an abnormal degree of narrowing of the sphincter 
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of Oddi canal and sphincter of Oddi dyskinesia; abnormal motility 
of the sphincter of Oddi, the present diagnostic criteria being a 
raised basal pressure (> 40mmHg) (Lans et al 1991). Since Oddi's 
description clinicians have attempted to elucidate the relationship 
between the sphincter of Oddi and clinical conditions suggestive of 
sphincter of Oddi dysfunction. Currently sphincter of Oddi dysfunction 
has been implicated in three clinical conditions post cholecystectomy 
pain syndrome, pancreatitis and right upper quadrant pain with the 
gallbladder in situ. 
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1.3.2 Post cholecystectomy pain syndrome 
Cholecystectomy is the commonest abdominal operation performed in 
the United Kingdom and the United States of America. The introduction 
of laparoscopic techniques in the late eighties' led to a dramatic rise in 
the number of cholecystectomies being performed per annum (Lam et 
al 1996) ( fig. 3). 
Fig 3 The cholecystectomy rate in Scotland 1977-1993 (Lam et al 
1996 
12OD 
100D Tctä 
CPM 
40 
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Hospital admission data for England shows that there were 35,772 
patients admitted for cholecystectomy in 1994 compared to 19,617 in 
1992. A number of studies have looked at the symptomatic outcome 
after cholecystectomy (Stefani et al 1974, Ros et al 1987). Stefani's 
group retrospectively assessed the outcome of 800 of the 1,716 
cholecystectomies performed at their centre between 1960 and 1973. 
The male to female ratio was 1: 2 and the age range was 13 to 84 
years.. A good result from cholecystectomy with maintained 
symptomatic relief of their right upper quadrant pain was achieved in 
68.9% whilst 31.1% continued to have symptoms postcholecystectomy. 
The prospective study by Ros et al 1987 reported 46% of patients 
continued to be symptomatic 2 years after cholecystectomy. The 
reported outcome from laparoscopic cholecystectomy is somewhat better 
with 77-95% of patients obtaining satisfactory symptom relief (Peters et 
al 1991, Velpen et al 1993, McMahon et al 1995, Luman et al 1996). 
The commonest post cholecystectomy symptoms include early satiety, 
post-prandial pain, flatulence, nausea, eructation and fatty food 
intolerance. Between five and thirty percent of patients with 
postcholecystectomy pain syndrome are thought to have sphincter of 
Oddi dysfunction (Bar-Meir et al 1984, Brandstatter et al 1991). 
As with gallbladder disease post cholecystectomy pain syndrome is 
more common in females, 2: 1 females: males (Donovan 1996); ` There 
is a significant impact on quality of life with an associated impact on 
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degree of absenteeism from work, disability and healthcare demands 
(Drossman et al 1993). 
Patients with postcholecystectomy syndrome have been classified into 
three types depending on their clinical presentation, the Milwaukee 
classification (Hogan et al 1987) (fig. 4). 
Fig. 4 The Milwaukee Classification (Hogan et al 1987) 
Type Biliary Pain Liver Biochemistry Common 
Bile duct 
Diameter 
1 Yes Abnormal Increased 
2 Yes Abnormal/ Normal Increased/ Normal 
3 Yes Normal Normal 
The types are differentiated on the basis of the presence of biliary 
pain with or without abnormal liver biochemistry and or common bile 
duct dilatation. This classification is not only useful in indicating which 
patients warrant further investigation but also for comparing the 
outcome from different therapeutic techniques. The common feature for 
types 1,2 and 3 is the presence of biliary type pain. Biliary pain has 
been defined by a panel of experts at the National Institutes of Health 
Consensus Conference on Laparoscopic Cholecystectomy (1993). 
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The characteristics of the pain are : 
1. It is severe, steady right upper quadrant or epigastric pain which is 
gradual in onset and lasts 2-5 hours. 
2. It customarily exceeds 3 month's duration and a single episode 
rarely lasts more than 24 hours. 
3. It is associated frequently with nausea, sweating and restlessness. 
The patient may walk about during periods of distress in an effort 
to gain relief. 
4. It occurs predominantly after meals and at intervals of weeks to 
years. 
5. That it may awaken the patient, peridoically, from sleep in the early 
morning hours. 
Sphincter stenosis results in the triad of symptoms found in type 1 and 
therapeutic sphincterotomy is often performed without further 
investigation. In types 2 and 3 further investigation is warranted to 
confirm or exclude the diagnosis of sphincter of Oddi dysfunction Lans 
et al 1991, Hogan et al 1997). 
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1.3.3 Pancreatitis 
In Western countries the most common known causes of acute 
pancreatitis are an excessive intake of alcohol or the presence of 
gallstones (Ranson 1982). In a significant proportion (10-40%) the cause 
is not found and these cases are classified as idiopathic pancreatitis 
(Ranson 1982). In idiopathic recurrent pancreatitis, sphincter of Oddi 
dysfunction has been found to be present and assumed to be the 
causal factor in a proportion of patients (figures 5 and 6). 
Fig. 5 Sphincter of Oddi manometry in patients with acute 
recurrent idiopathic pancreatitis. 
Author (ref) No. of Patients No. with SO Good outcome 
dysfunction (%) to Treatment 
(%) 
Raddawi et al 24 7(29) - 
1991 
Sherman et al 168 89(53) - 
1991 
Toouli et al 28 25(89) - 
1985 
Toouli et al 26 - 88 
1985 
Venu et al 116 17(15) 94 
1989 
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Fig. 6 Various aetiological factors identified in patients with 
idiopathic recurrent pancreatitis 
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Pancreatic pain differs from biliary pain in that it is constant severe 
pain which is located in the epigastric and left upper quadrant pain, or 
the entire abdomen and in 50% of patients it radiates to the back and 
occasionally to the left anterior chest wall, left shoulder, or the lower 
abdomen. In pancreatitis the pain in the lower abdomen is believed to 
be due to pancreatic exudate spreading via the transverse mesocolon 
to the caecum along the left colon. The pain is usually more intense 
in the upper than the lower abdomen (Banks PA 1979, Banks PA 
1986. 
Venu et al 1989 investigated 116 patients with idiopathic recurrent 
pancreatitis. Forty-four (38%) were found to have a demonstrable cause 
for their pancreatitis as shown in table F. Seventeen (15%) were found 
to have sphincter of Oddi dysfunction as characterized by a significantly 
elevated basal pressure at manometry. Ten of the seventeen had a 
paradoxical response to cholecystokinin-octapeptide provocation (a rise In 
basal sphincter of Oddi pressure). Treatment was undertaken in sixteen 
of the seventeen (12 with endoscopic sphincterotomy and four operative 
sphincterotomy). These sixteen remained symptom free fora period of 
36 ±4 months. Toouli et al 1996 reported a prospective study in a 
selected group of patients with idiopathic recurrent pancreatitis due to 
sphincter of Oddi dysfunction. Over a ten year period thirty-five patients 
were found to have sphincter of Oddi dysfunction at manometry 
following the exclusion of common causes of pancreatitis. A total of 
twenty-six underwent operative sphincteroplasty and septoplasty (21 as 
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initial therapy, 2 after failure of conservative therapy and 5 after failure 
of endoscopic sphincterotomy). Patients were followed-up for a median 
of twenty-four months (range 9-109) and fifteen (58%) patients reported 
no further symptoms and were deemed as being cured, eight (31%) 
patients had only mild symptoms and were treated with mild analgesics. 
three (11%) patients had no improvement in their symptoms. It was 
concluded from this study that division of the sphincter of Oddi is 
associated with good symptomatic outcome in patients with recurrent 
episodes of pancreatitis and documented sphincter of Oddi dysfunction. 
Patients with pancreatic sphincter dysfunction have been classified in a 
similar way to the Milwaukee classification by Sherman et al 1991 
(fig. 7). 
Fig 7 THE CLASSIFICATION OF PANCREATIC TYPE SPHINCTER 
OF ODDI DYSFUNCTION 
Type Pancreatic pain Recurrent 
Pancreatitis 
Dilated 
Pancreatic 
Duct 
1 Yes Yes Yes 
2 Yes No/ Yes No/ Yes 
3 Yes No No 
It is not clear how sphincter of Oddi dysfunction leads to intermittent 
recurrent episodes of pancreatitis. It is possible that a rise in main 
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pancreatic duct pressure leads to pancreatic secretions being forced 
back into the pancreatic acini in a similar way that acinarization occurs 
after contrast is over injected into the pancreatic duct at endoscopic 
retrograde pancreatography. Alternatively increased tissue pressure due 
to increased intraductal pressure may lead to intra-acinar cell activation 
of digestive zymogens which are believed to be the earliest events in 
the evolution of acute pancreatitis. These enzymes, once activated, 
cause acinar cell injury (Saluja et at 1989, Grady et at 1996). 
The commonest cause of chronic pancreatitis is the excessive intake of 
alcohol, the increase in cases of chronic pancreatitis in industrialized 
countries parallels a marked increase in alcohol consumption (Worning 
1990)1)26904). There is a linear relation between alcohol consumption and 
the logarithmic risk for chronic pancreatitis (Durbec et al 1978). As well 
as alcohol exerting a damaging effect directly on the gland, it also acts 
on the sphincter of Oddi. Studies using T-tubes have shown that 
intragastric (Capitane et al 1971) and intravenous (Pirola et `al 1968) 
alcohol increases sphincter of Oddi tone. A more recent study using a 
perfused catheter looked at the direct effect of alcohol (3mls of 40% 
alcohol) on the sphincter and showed a significant increase in basal 
pressure without a change in the phasic activity (Guelrud et al 1991). 
An abnormal sphincter response to secretin (a rise in basal sphincter 
pressure) ' has been found in patients who chronically abuse alcohol 
with a rise in main pancreatic duct and sphincter pressures (Bradley et 
al 1982). It is therefore possible that the direct effect of alcohol on the 
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sphincter of Oddi may be a significant factor contributing to the 
development of chronic pancreatitis (Bradley et al 1982). In up to 20% 
of cases of chronic pancreatitis there is no causal factor found, and it 
is possible that pancreatic sphincter dysfunction may be responsible for 
precipitating a proportion of these cases. In a recent study (Fogel et al 
1997), 102 patients with chronic pancreatitis in whom 56% had 
undergone a prior sphincterotomy of either or both ducts were 
investigated. The frequency of sphincter of Oddi dysfunction was 62% 
in the patients classified as having mild chronic pancreatitis, 27% in 
those patients with moderate chronic pancreatitis and 27% in those 
with severe chronic pancreatitis. 
There have been several studies suggesting that the pain of chronic 
pancreatitis may be a result of increased pancreatic ductal pressure in 
some patients (Bradley et al 1982, Carr-Locke et al 1985 and Ebbehoj 
et at 1990). This has been supported by the finding that surgical 
decompression of the pancreatic duct in these patients isý effective in 
relieving abdominal pain and that pain relief is associated with 
normalization of the pancreatic duct pressure. 
In summary, these studies all suggest that sphincter of Oddi 
dysfunction may play a' part in the pathogenesis of chronic pancreatitis 
whether as a direct effect or one mediated by the chronic abuse of 
alcohol. However there is, as yet, only preliminary data to support this 
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supposition and these effects may prove to be a secondary 
phenomenon. 
1.3.4 Right upper quadrant pain with the gallbladder in situ 
The presence and the role of sphincter of Oddi dysfunction with the 
gallbladder in situ is even more controversial. Two small studies 
(Choudhury et al 1993 and Catalano et al 1991) treated patients with 
right upper quadrant pain with intact gallbladders and elevated sphincter 
of Oddi basal pressures with endoscopic sphincterotomy. Both studies 
described good initial pain response rates (77% and 83%, respectively) 
but there was a high relapse rate in both studies and a high incidence 
of procedure-related pancreatitis. A more recent study (Catalano et al 
1998) again with only limited numbers but stratified according to the 
Milwaukee classification reported a more favorable outcome initially, but 
at final follow-up, 46.4 months (range 10-111 months), the outcome 
was less favorable with resolution of symptoms in only 54% of type 2 
and 36% of type 3 patients. 
It has also been noted that abnormalities of gallbladder and sphincter 
of Oddi motility may occur concomitantly, though there is no clear-cut 
common aetiological factor (Ruffalo et al 1994). Toouli et al 1986 
compared sphincter of Oddi motility in patients undergoing elective 
cholecystectomy for gallstones with a control group. In the control 
group, their sphincter of -Oddi exhibited predominantly antegrade 
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contractions whereas the sphincter of Oddi of patients undergoing 
cholecystectomy had a predominance of retrograde contractions. This 
suggests that a primary sphincter of Oddi motility disorder has resulted 
in the development of gallstones or that the presence of gallstones has 
led to sphincter dysmotility. 
Gallbladder dyskinesia is equally as controversial a subject as sphincter 
of Oddi dysfunction. It is possible that the problem with patients with 
right upper quadrant pain and an intact gallbladder in the absence of 
stones still lies with the gallbladder rather than the sphincter of Oddi 
and is due to gallbladder dyskinesia (also known as acalculous 
cholecystitis). This diagnosis is difficult to make as it has been found 
that 66% of patients diagnosed as having acalculous cholecystitis by 
ultrasound are in fact found to have stones on further imaging (Ekberg 
et al 1991). There has also been growing recognition of the clinical 
importance of biliary microcrystals. - The standard diagnostic modality 
was cholecystography after an intravenous bolus of cholecystokinin. The 
finding of reduced gallbladder contractility, being indicative of gallbladder 
dyskinesia, however this test has a rather mixed reputation due to the 
inherent subjectivity. ( Goldstein et al 1974, Berk et al 1977, Davis et 
al 1982, Rhodes et al 1988). More recently a quantitative method of 
measuring the gallbladder ejection fraction by DISHIDA (Digital 
subtraction imaging HIDA scan (99mTc-labelled dimethyl-acentanilide 
iminodiacetic acid)) with concurrent cholecystokinin injection , quantitative 
cholescintigraphy, has been developed (Yap et at 1991). Yap et al's 
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randomized study of eighty-seven patients with chronic right upper 
quadrant pain, twenty-six were found to have an abnormal gallbladder 
ejection fraction (less than 40%±3 SD). These twenty-six patients were 
subsequently randomized to operative or conservative therapy. All 
thirteen patients with abnormal ejection fractions randomized to 
cholecystectomy had confirmed histological evidence of chronic 
cholecystitis and these patients did significantly better than those 
patients treated conservatively. The remaining fifty-nine patients with 
normal ejection fractions showed no significant or predictable outcome 
difference whether treated by cholecystectomy or conservatively. There 
are other studies to support quantitative cholescintigraphy (Peng et al 
1994, Ruffolo et al 1994) however, there has been at least one study 
questioning its efficacy (Westlake et al 1990). A single study has 
shown that acalulous cholecystitis, assessed by quantitative 
cholescintigraphy, and sphincter of Oddi dysfunction, assessed by 
sphincter of Oddi manometry, may coexist (Pasricha et al 1993). Of 
the twenty-five patients studied with right upper quadrant pain and 
intact gallbladders, five patients were found to have decreased - 
gallbladder ejection fractions and had acalculous cholecystitis 
demonstrated at cholecystectomy. Five patients were found to have 
raised basal sphincter of Oddi pressures and symptoms resolved 
following sphincterotomy. Two patients were found to have both 
abnormal gallbladder ejection fractions and raised sphincter of Oddi 
basal pressures, they were both treated with endoscopic sphincterotomy 
with satisfactory outcomes. 
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1.4 METHODS OF MEASUREMENT OF SPHINCTER OF ODDI 
FUNCTION AND DYSFUNCTION 
Invasive and non invasive methods have been developed to assess 
sphincter. of Oddi function. This section will discuss advantages and 
disadvantages of each diagnostic modality and compare them against 
endoscopic manometry (the present "gold standard" method). 
Non Invasive 
1.4.1 The Morphine-Neostigmine/ Prostigmine Provocation test. 
The basis of this test is the action of each component, morphine and 
prostigmine on the sphincter of Oddi. In one subgroup of patients with 
suspected sphincter of Oddi dysfunction, morphine has been found to 
aggravate biliary-type pain, particularly after cholecystectomy via its 
contractile action on the sphincter of Oddi. As long ago as 1936 a 
study by McGowan reported that morphine given subcutaneoulsy 
increased common bile duct pressures in patients with a T-tube 'in situ 
and this was associated with the onset of abdominal pain. Neostigmine 
(Knight et al 1959) and morphine (Burke et al 1950) have both been 
shown to lead to rises in serum amylase in a proportion of patients 
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with relapsing pancreatitis and bilary type pain. Following these 
observations the combination of morphine and neostigmine were 
promoted as a provocation test in patients with abdominal pain due to 
inflammatory disorders of the sphincter of Oddi (Nardi et at 1966). This 
test, as first described by Nardi et at 1966, was performed by giving 
the patient an intramuscular injection of morphine sulphate 1 0mg and 
neostigmine 1 mg, followed by four, hourly blood samples for the 
measurement of serum amylase and lipase. Ina positive result a 
fourfold rise in amylase and lipase was observed along with the 
development of abdominal pain. Subsequent modifications on this 
protocol have been made along with inferences to their diagnostic 
implications (Milano et al 1973, Nardi et al 1974, Raskin et al 1977, 
Lonmire et al 1977, Gregg et al 1977 and LoGiudice et al 1979). A 
positive result was suggested as a twofold enzyme rise and a 
reproduction of abdominal pain (Milano et a11973, Nardi et al 1974). 
Other groups have suggested that the enzyme rise alone without the 
reproduction of pain is of paramount importance (Lonmire et al 1977, 
Raskin et al 1977). Gregg et al 1977 found that a five fold increase 
in lipase after a morphine-neostigmine is associated with a difficult 
papilla to cannulate at endoscopic retrograde cholangiopancreatography 
due to papillary stenosis. Buntain et al 1986 found this provocation test 
to be useful in defining the cause of some cases of chronic relapsing 
pancreatitis in children. 
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Unfortunately controlled studies have failed to validate the morphine- 
neostigmine test as a useful clinical tool for the diagnosis of sphincter 
of Oddi dysfunction (LoGiudice et al 1979 and Steingberg et at 1980). 
In LoGuidice's study, endoscopic manometry and operative assessment 
showed good correlation, but the morphine-prostigmine test failed to 
correlate with either of these parameters. Moreover three of the six 
healthy controls also had a significant enzyme rise. Similarly the 
morphine-prostigmine test was shown to give a significant false positive 
result in healthy volunteers and failed to provide reproducible results in 
patients studied by Steinberg et al. 
We can conclude from these studies that the morphine-neostigmine test 
is not a useful clinical tool for the investigation of sphincter of Oddi 
dysfunction. 
1.4.2 Ultrasonographic diagnosis of sphincter of Oddi dysfunction 
Simple sonographic measurement of the common bile duct diameter 
(Thatcher et al 1987) and dynamic measurement studies following a 
fatty meal (Simone et al 1982) or CCK (Fein et al 1984) have been 
proposed as methods of diagnosing sphincter of Oddi dysfunction. 
After cholecystectomy, a dilated common bile duct detected using 
ultrasonography has been suggested as a feature of sphincter of Oddi 
dysfunction that has a positive predictive value in the outcome for 
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therapy with sphincterotomy (Thatcher et al 1987). However dilatation of 
the common bile duct in asymptomatic patients after cholecystectomy is 
not an uncommon finding (up to 16%) (Garham et al 1987). It has also 
be shown that the common bile duct diameter varies with age (Coehlo 
et al 1996). Therefore common bile duct ' diameter cannot be used as 
the sole diagnostic indicator for the diagnosis of sphincter of Oddi 
dysfunction. 
The dynamic response of the sphincter of Oddi and the resulting 
dilatation of the common bile duct is another proposed diagnostic tool. 
The fatty meal ultrasound involves the measurement of the common 
bile duct diameter by ultrasound 45 minutes after ingestion of a 
standard meal of lipomul (1.5ml/lb body weight). In normal patients the 
common bile duct diameter remains unchanged following a fatty meal 
or intravenous cholecystokinin in spite of the resulting increased bile 
output. This is because the sphincter of Oddi relaxes and allows bile 
flow into the duodenum. An increase in common bile duct diameter 
greater than 2mm resulting from failure of relaxation or possibly 
contraction of the sphincter in response to a fatty meal or 
cholecystokinin has been observed in patients with sphincter of Oddi 
dysfunction (Fein et al 1984). One study of forty-four controls and forty- 
seven patients with suspected partial common bile duct obstruction 
showed a specificity of 100% and a sensitivity of 74% (Darweesh et at 
1988). In this study fatty meal ultrasound correctly identified seven of 
the eight cases with manometrically proven sphincter of Oddi 
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dysfunction. A subsequent study failed to show a significant correlation 
between fatty meal ultrasound and endoscopic manometry in thirty-one 
patients with suspected sphincter of Oddi dyskinesia (Milwaukee type 3) 
(Dean et al 1991). Fatty meal ultrasound may be a reasonable non- 
invasive dynamic screening test, particularly in patients with right upper 
quadrant pain and an intact gallbladder. 
Dynamic studies have also been used to investigate the pancreatic 
sphincter (Bolondi et al 1984). The diameter of the pancreatic duct in 
normals is 1.2 ± 0.4mm. After secretin injection (1 CU/Kg to a maximum 
of 75CU) there is increased secretion from the pancreas and a 
subsequent increase in pancreatic duct diameter that lasts for less than 
thirty minutes. If the pancreatic duct remains dilated after thirty 
minutes (>1.5mm) then it is suggestive of pancreatic outflow resistance. 
A dynamic test based on this observation has been proposed as a 
useful screening test to alert the clinician to the possibility of sphincter 
of Oddi dysfunction (Toouli et al 1996, Tzovaras et al 1998). 
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1.4.3 Hepatobiliary scintigraphy 
Hepatobiliary scintigraphy or cholescintigraphy is performed by computer 
analysis of the excretion of a radioisotope- labeled tracer (usually 
99rnTechnetium labelled dimethyl- iminodiacetic acid) using a gamma 
camera. For regions of interest i. e. the right lobe of the liver, liver 
hilum and the common bile duct, the computer generates time activity 
curves. This method has been standardized, and can give quantitative 
and qualitative information by measuring a significant delay in hepatic 
uptake and washout (Steinberg et al 1988). Abnormal results suggestive 
of sphincter of Oddi dysfunction are determined by the elevated hilar 
time-activity curve and reduced 45 minute clearance value (Fullarton et 
al 1988). Fullarton et al's findings showed a statistically significant 
difference in scintigraphic analysis in patients with sphincter dysfunction 
(confirmed by endoscopic manometry) compared with asymptomatic 
controls, and it was proposed that this to could be a useful non- 
invasive screening test for sphincter of Oddi dysfunction, however, 
subsequent studies have been less convincing (Lisbona et al 1992). 
The main problem with this technique is the difficulty in differentiating 
between parenchymal liver disease, intrahepatic cholestasis and 
extrahepatic bile duct pathology (Steinberg et al 1988, Coehlo et al 
1996). This has led to the development of techniques involving 
prestimulation with cholecystokinin (Sostre et al 1992). Cholecystokinin 
acts as a functional stimulus to accentuate differences in bile flow rates 
between a normal post cholecystectomy population and those with 
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sphincter of Oddi dysfunction. A scoring system has been developed 
incorporating all the variables previously demonstrated to be of 
significance in the diagnosis of sphincter dysfunction i. e: time of peak 
liver activity, time at which the intrahepatic biliary tree is first visualized, 
prominence or dilatation of the biliary tree, time at which the bowel is 
first visualized, percentage of common bile duct emptying and common 
bile duct: liver ratio. This scoring system is superior to previous 
diagnostic criteria with a sensitivity of 100% and specificity of 100% for 
the diagnosis of sphincter dysfunction (Sostre et at 1992). This 
conclusion is limited by the fact that these results were obtained from 
with small patient (n=12) and control (n=14) populations. No subsequent 
confirmatory studies have been performed and more importantly this 
scoring system has not been used to assess its predictive merits in 
indicating a favourable outcome from therapeutic techniques such as 
sphincterotomy. 
In conclusion modified quantitative Hepatobiliary scintigraphy using 
cholecystokinin pretreatment may be a suitable non invasive screening 
test for sphincter of Oddi dysfunction. It usefulness may be limited by 
the necessary exposure to gamma irradiation. 
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Invasive 
1.4.3 Endoscopic manometry 
Manometry is regarded as the "gold standard" for the evaluation of 
sphincter of Oddi function. There are two methods, a perfused catheter 
technique and a microtransducer technique. 
1.4.4 Perfused Catheter Technique. 
The first description of perfused catheter endoscopic manometry was in 
1974 from Germany (Vondrasek et al 1974). Subsequent perfused 
catheter manometric methods were reported in the literature but their 
focus was on measuring pressure within the biliary or pancreatic ducts 
rather than the sphincter of Oddi (Vondrasek et al 1974, Nebel et al 
1975, Rolny et at 1991). 
The first method for measuring actual sphincter activity was described 
by Geenen in 1978. Pressure recordings were obtained using two 
Teflon catheters each of an internal diameter of 0.8 mm, an outer 
diameter of 1.6mm and length of 200cm. A lateral recording orifice was 
cut into each catheter 3mm from the end, and the catheter lumen 
distal to this orifice was sealed with glue. One catheter (the ductal 
catheter) was introduced into the biliary or pancreatic sphincter via the 
biopsy channel of a fibreopitic duodenoscope. The ductal catheter was 
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slowly withdrawn from the bile or pancreatic duct through the respective 
sphincters, a pull-through technique. The second catheter was attached 
to the outside of the duodenoscope and continually measured duodenal 
pressure. Both catheters were perfused with bubble free water at a 
rate of 0.25ml/min, by a minimally compliant hydraulic-capillary infusion 
(Arndorfer et al 1977) system driven by a constant reservoir pressure 
of 750mmHg (Geenen et al 1980, Geenen et al 1995). Pressure 
measurements were obtained when the sphincter compressed the 
catheter resulting in partial occlusion of the measuring orifice, the 
occlusion pressure was transmitted back up through the catheter via 
the column of perfused water to an external transducer. The external 
transducer transformed the readings into an electrical signal which was 
then amplified, displayed and recorded. 
Subsequently the commercially made and now widely used Lehman 
(Wilson-Cook, USA) catheter was developed. This is a triple lumen five 
french catheter with two measuring ports orientated 180 degrees apart 
and 2mm apart in distance, the third central channel opens at the 
catheter tip (Plate B). Water perfusion and pressure transduction is 
performed as before. The central lumen facilitates decompression of the 
duct being measured by continual aspiration, this is known as the 
modified aspiration technique. The modified aspiration technique has 
been shown significantly reduce the complication rate from procedure 
related pancreatitis (31% to 4%) without significantly altering the 
pressure recordings (Sherman et al 1990, Sherman et al 1990). 
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Plate B: The Lehman triple lumen catheter 
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The risk of procedure related pancreatitis has been shown to be 
greatest when the pancreatic duct is cannulated and pressures are 
recorded from the pancreatic sphincter. High perfusion flow rates is 
54 
The catheter tip marked in 10 2mm sections 
another independent risk factor for inducing pancreatitis (Staritz et al 
1991). The Lehman catheter enables easy differentiation between the 
ducts cannulated, the presence of bile as the aspirate confirms that the 
biliary sphincter is being assessed whereas clear aspirate indicated 
pancreatic duct cannulation. Thune et al 1991 and others (Geenen et 
al 1989, Smithline et al 1993, Guelrud et al 1990) have confirmed that 
this technique gives reproducible results. 
The "pull-through" technique (through ten 2mm apart stages) has now 
been standardized, two recordings are made to demonstrate the 
sphincter pressure profile and to localize the point of peak basal 
pressure for subsequent pressure recordings and an additional 
pharmacological challenge with cholecystokinin. (Hogan et al 1997). 
Computers rather than chart recorders are now used to capture and 
display the output from the pressure transducers. Software is 
commercially available for performing oesophageal manometry and these 
programs can be easily adapted to perform sphincter of Oddi 
manometry. An example of a typical normal recording taken from our 
own laboratory is shown in Plate C. Duodenal pressure is shown by 
channel 1 and the proximal and distal ports of the manometry catheter 
are displayed as channel 2 and 3 respectively. 
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Plate C: A "normal" sphincter of Oddi manometrv recording from 
our laboratory 
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The sphincter of Oddi pressure is denoted by the rise above the bile 
duct baseline in the proximal port (channel 2), followed by the distal 
(channel 3) port 2mm later. Regular phasic activity can be seen as the 
catheter is withdraw. The sphincter of Oddi basal pressure is calculated 
from the net of the sphincter pressure and duodenal pressure. A 
summary of the pressure measurements from studies on "normal 
volunteers" (fig. 8). 
Basal pressure is the most important parameter measured and most 
authorities agree that an abnormal basal pressure is greater or equal 
to 40mmHg (two standard deviations above the median basal pressure) 
(Gandolfi et at 1986, Funch- Jensen et al 1982, Gennen 1980). The 
direction of the phasic activity can be seen by following a wave from 
distal through the proximal port, normal contractions have an amplitude 
between 50-150mmHg with mostly antegrade propagation. The 
manometric abnormalities ascribed to sphincter of Oddi dysfunction 
other than a raised basal pressure are an increased amplitude of 
phasic activity (> 240mmHg), an increased frequency (> 6 per minute) 
of phasic contractions and an increased percentage of retrograde 
contraction (>50%) (Barinagarremen et al 1991, Lans et al 1991, Thune 
et al 1991, Blades et al 1993). However a raised basal pressure 
appears to be the most consistent, reliable and frequently used variable 
for the diagnosis of sphincter of Oddi dysfunction (Gilbert et at 1992, 
Blades et al 1993). From cumulative historical data, standardized 
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normal and abnormal reference ranges for basal pressure and phasic 
activity have been defined (Toouli et al 1990) (fig. 9). 
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Fig 9 "Normal" values for sphincter of Oddi manometry (Toouli 
et at 1990) 
Normal Abnormal 
Basal Pressure ( mmHg) 
Median 
15 
Range 
5- 35 > 40 
Amplitude ( mmHg) 135 95 - 195 > 300 
Frequency ( n/ min) 4 2-6 >6 
Sequences 
Antegrade (%) 80 12 - 100 
Simultaneous (%) 13 0- 50 
Retrograde (%) 9 0- 50 > 50 
Cholecystokinin 20ng/kg Inhibits Contracts 
The sphincter pressure profile is similar, when recording from the biliary 
or pancreatic sphincters in normal subjects (Carr-Locke et al 1981. 
Raddawi et al 1991) by contrast, there are many reported instances in 
which differing pressures are recorded from each sphincter in 
symptomatic patients (Toouli et al 1985, Stone et at 1988, Funch - 
Jensen et al 1987, Okazaki et al 1988, Dodds et al 1990, Raddawi et 
al 1994, Geenen et al 1995, Berezny et al 1985). Raddawi et al 
reported eight of nineteen patients with biliary symptoms had elevated 
sphincter of Oddi pressure and in five (62.5%) of the eight it was 
61 
confined exclusively to the biliary sphincter. Seven of twenty-four 
patients with acute recurrent pancreatitis had an elevated sphincter of 
Oddi basal pressure and in five (72%) of the seven the pancreatic 
sphincter pressure only was elevated. It is therefore important that the 
catheter is positioned in the appropriate sphincter reflecting the clinical 
suspicion of biliary or pancreatic disease. 
As with the non-invasive techniques the dynamic response to 
intravenous hormones has been investigated with some very interesting 
findings. Hogan et al reported in 1982 that five patients with suspected 
sphincter of Oddi dysfunction had a paradoxical increase in biliary 
sphincter pressure in response to exogenous cholecystokinin. Evan's et 
al 1995 found in a group of patients with post cholecystectomy pain 
syndrome a paradoxical rise in sphincter of Oddi basal pressure in 
response to cholecystokininin in a group of patients with associated 
irritable bowel syndrome, although there were no other differences in 
basal pressure or phasic activity between those with or without irritable 
bowel syndrome (Evans et al 1995). The response to sphincterotomy in 
patients with a paradoxical response to cholecystokinin has only been 
assessed by one group (Rolny 1986)'}8524). Eight of ten such patients 
experienced symptomatic relief following sphincterotomy with a follow-up 
period of 11-16 months. 
Secretin has been used to assess the dynamic response of the 
pancreatic sphincter. Secretin acts to relax the pancreatic sphincter but 
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has no effect on common bile duct or biliary sphincter pressure (Carr- 
Locke et al 1985). Patients with chronic pancreatitis have been shown 
to have a prolonged elevation in main pancreatic duct pressure after 
secretin (1 CU/Kg) compared with controls (Toouli et al 1985). More 
recently alcoholic patients (n=27) without evidence of pancreatic disease 
have been found to have a paradoxical elevation in sphincter basal 
pressure in response to secretin (1 CU/kg) but not to cholecystokinin 
(75ng/kg) (Laugier et al 1998). It is possible that this abnormal 
response is a factor in the aetiology of chronic pancreatitis. 
There is some debate about which patients should be investigated with 
endoscopic manometry. Sixty-five to ninety percent of the patients who 
have post cholecystectomy pain syndrome and fall into type 1 of the 
Milwaukee classification (table D) have abnormal sphincter of Oddi 
manometry (Stone et 1988, Sherman et al 1991) and endoscopic 
manometry is therefore regarded as an optional diagnostic modality. 
Approximately sixty percent of the patients within biliary type 2- have 
abnormal manometry and therefore manometry is regarded as essential 
(Sherman et al 1991, Lans et al 1991). A raised basal sphincter 
pressure is less common in biliary type 3 (12-35 %) (Lans et al 1991) 
and hence manometry is regarded as critical. There are no studies 
reporting the outcome of patients within Sherman classification 
pancreatic types 1 to 3 and pancreatic sphincter dysfunction but 
manometry it is recommended to make the diagnosis in pancreatic 
63 
types 2 and 3 but is not essential for patients classified as type 1 
(Lans et al 1991). 
Endoscopic manometry as with endoscopic retrograde 
cholangiopancreatography is performed with the patient sedated. Clearly 
the action of any sedative or analgesic drug on the sphincter of Oddi 
must be known prior to sphincter of Oddi manometry. Diazepam and 
midazolam are the commonest sedatives used and these do not alter 
the sphincter profile (Ponce Garciia et al 1988, Rolny et al 1993, Cuer 
et al 1993). In some centres endoscopic manometry is performed 
without the addition of a analgesia (Allescher et al 1993) but the 
patient is often less cooperative, which, -may prolong the study, 
jeopardize the accurate recording of sphincter pressures, lead to the 
use of excessive sedation and may potentially increase the risk of post 
procedure complications (Hogan et al 1997). Pethidine is the analgesic, 
it does not alter sphincter basal pressure but phasic activity is 
increased (Elta et al 1994, Sherman et al 1996). More recently 
propofol has been proposed as an effective alternative to 
benzodiazipines and both canine (Baron et al 1994) and human (Goff 
1995) studies have not shown an adverse effect sphincter motility. The 
action of general anaesthetics on sphincter activity in humans or large 
animals is not known. Pharmacological agents that are commonly used 
to aid cannulation at endoscopic retrograde cholangiography such as 
buscopan and glucagon clearly will alter sphincter motility and are 
therefore avoided. 
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1.4.5 Microtransducer endoscopic manometry 
This technique has largely been utilized in Japan an Eastern countries 
(Okazaki et al 1984, Tanaka et al 1983, Tanaka et al 1984, Tanaka et 
al 1985, Okazaki et al 1988, Okazaki et al 1998, Okazaki et al 1988, 
Nishimori et al 1990, Yamasaki et al 1993). The microtransducer method 
has a miniature strain gauge pressure transducer mounted at the tip of 
a catheter. This technique was pioneered and data published in the 
same year as the perfused catheter, 1974 by von Vandrasek and 
Eberhardt. Subsequently two types of strain gauge catheters were 
developed (Yamada et al 1980, Kobayashi et al 1985, Mori et al 
1989), one to record ductal pressure and the other to record sphincter 
of Oddi contractions. With the progressive developments in endoscopic 
instruments and techniques for cannulation, Tanaka et al 1981 
succeeded in measuring pancreatic and common bile duct pressures in 
many patients with an intact papilla for the first time, using a4 French 
diameter microtransducer catheter. This group are unique in their 
success in placing a catheter within the common bile duct and 
removing the duodenoscope thus allowing prolonged recordings (Tanaka 
et al 1983, , 
Tanaka et al 1988).. 
The drawback of this method is that it is difficult to position and 
maintain the transducer within the high pressure zone of the sphincter 
of Oddi and therefore most studies have assessed biliary or pancreatic 
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duct pressures rather than sphincter of Oddi pressures (Okazaki et al 
1984, Okazaki et al 1988, Okazaki et al 1988, Okazaki et al 1988, 
Okazaki et al 1989, Tanaka et al 1992). The strain gauge 
microtransducer catheter is extremely fragile and easily damaged when 
passed through the duodenoscope. As there is often only one 
microtransducer per catheter it is not possible to measure wave 
propagation (Tanaka et al 1981). this method is not favoured in the 
West. In general the pressure measurements from the microtransducer 
catheter are lower than from a perfused catheter (Tanaka et al 1981). 
In summary, the perfused catheter is the most widely used and 
preferred technique in the Western world and Australia, whereas 
Japanese groups prefer the solid state microtransducer catheter. The 
perfused catheter has a number of advantages over the solid state 
catheter, it is more robust and wave propagation can be evaluated. 
The advantage of the microtransducer is that it is a smaller catheter 
and the scope can be removed over the catheter allowing longer 
studies to be performed. 
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1.5 THERAPY FOR SPHINCTER OF ODDI DYSFUNCTION 
The aim of treatment for sphincter of Oddi dysfunction is to lower 
basal pressure and facilitate drainage of biliary or pancreatic secretion 
into the duodenum. There are a number of invasive and non invasive 
methods to lower basal pressure but endoscopic sphincterotomy is 
regarded as the principal therapeutic technique. 
Invasive therapeutic techniques 
1.5.1 Endoscopic sphincterotomy. 
Endoscopic biliary sphincterotomy was first described in 1974 by 
Demling et al and Nakajima et al four years after the first diagnostic 
endoscopic retrograde cholangio-pancreatography. The technique rapidly 
became popular for the management of bile duct stones, especially in 
elderly and frail patients judged to be poor candidates for operation. A 
typical sphincterotomy is demonstrated in plate D. 
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PLATE D: AN ENDOSCOPIC BILIARY SPHINCTEROTOMY USING A 
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BOWSTRING SPHINCTEROTOME 
Endoscopic sphincterotomy has been shown to lower basal biliary 
sphincter pressure (Tanaka et al 1981). The response to sphincterotomy 
in patients with sphincter of Oddi dysfunction and a raised basal 
pressure is variable. Patients classified as Milwaukee type 1 often do 
not need to undergo biliary manometry and undergo endoscopic 
sphincterotomy as a primary diagnostic and therapeutic manoeuvre 
(Lans et al 1991, Classen et al 1981, Weitemeyer et al 1982). 
However, restenosis is not uncommon and occurred in four (25%) of 
the twenty-five in Lans et al's study. 
The most important and unique study to assess the efficacy of biliary 
endoscopic sphincterotomy was performed by Geenan et al 1989. In 
this double blind study forty-seven post cholecystectomy patients with 
type 2 sphincter of Oddi dysfunction were randomly assigned to 
undergo either endoscopic sphincterotomy or sham sphincterotomy 
(performed in exactly the same way as a true sphincterotomy, except 
that the sphincterotome was positioned in the duodenal lumen during 
the activation of the electrocautery unit). Sphincterotomy resulted in 
improvement in pain scores (p=<0.05) at one year follow-up in ten of 
the eleven patients with elevated sphincter pressure. In contrast, there 
was improvement in only three of the twelve patients who underwent 
the sham procedure (figures 10 and 11). In those patients with normal 
sphincter pressures there was no difference in response regardless of 
treatment. After one year sphincterotomy was performed in twelve 
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Fig. 10 CLINICAL OUTCOME OF BILIARY TYPE 2 PATIENTS AT 1 
YEAR FOLLOW-UP BASED ON THEIR CLINICAL AND OBJECTIVE 
ASSESSMENT (GEENEN ET AL 1989) 
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<40 mmHg >40 mmHg 
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Fig 11 CLINICAL OUTCOME OF BILIARY TYPE 2 PATIENTS 
AT 4 YEAR FOLLOW-UP (GEENEN ET AL 1989) 
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Sham ES Sham ES 
symptomatic patients who had undergone the sham procedure. At four 
year follow-up seventeen of the eighteen with elevated sphincter 
pressures benefited from sphincterotomy. This outcome has now been 
shown to persist at 12 year follow-up (Kaikaus et al 1995). Subsequent 
prospective studies have confirmed the efficacy of sphincterotomy in 
type 2 patients but to date have failed to show benefit in type 3 
patients (Bozkurt 1996, Wehrmann 1996). 
Although sphincterotomy is efficacious it carries with it significant risks 
of pancreatitis, bleeding and perforation. The complication rate from 
sphincterotomy, performed for all diagnoses, is about 10% with an 
overall mortality of 1.5% ( Cotton et al 1991, Freeman 1997, Sherman et 
al 1997). The complication rate is highest in patients with sphincter of 
Oddi dysfunction (Freeman 1997) and in patients without a dilated 
bilary tree (Chen, et al 1994). It is thought that the elderly patient with 
poor pancreatic function is protected against pancreatitis after 
sphincterotomy. In comparison, patients with sphincter of Oddi 
dysfunction are often young, with good pancreatic function and 
therefore have greater risk of developing pancreatitis. The technique of 
precut biliary sphincterotomy without prophylactic stenting of the 
pancreatic duct is an independent risk factor for developing a 
sphincterotomy complication (Freeman 1997). In the past, endoscopic 
pancreatic sphincterotomy without stenting has been performed in 
patients with sphincter of Oddi dysfunction (Weitemeyer et al 1994, 
Sherman et al 1991, Sherman et al 1994) and has been shown to be 
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even more hazardous in patients with pancreatic sphincter hypertension 
(Tarnasky et al 1997). The risks may be reduced if the sphincterotomy 
is performed as a needle knife cut down onto a pancreatic stent, 
following the cut the stent is left is situ to allow pancreatic drainage ( 
Sherman et al 1997, Tarnasky et al 1997). For this reason it has been 
proposed that the pancreatic duct should be prophylactically stented 
prior to all procedures, even biliary sphincterotomy in patients with 
sphincter of Oddi dysfunction (Sherman et al 1997, Tarnasky et al 
1997). More recently, Elton et al 1998 reported that pancreatic 
sphincterotomy with overnight nasopancreatic drainage was as safe as 
prophylactic stenting, negated the need for repeat duodenoscopy to 
remove the stent and confirmed that pancreatic sphincterotomy was 
safer with a drainage procedure than without (pancreatitis rate 12.5% 
with no drainage procedure compared" with 0.7% with p=<0.003). At 
present the efficacy of lone pancreatic sphincterotomy is poor, some 
evidence exists showing selected patients may benefit ( Kozarek et al 
1994), but this study was limited by its-size. More surprisingly is the 
finding that Idiopathic recurrent pancreatitis may respond to endoscopic 
or surgical biliary sphincterotomy (Venu et al 1989, Toouli et al 1996, 
Lahoti et al 1996). 
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1.5.2 Surgical sphincteroplasty 
Transduodenal sphincteroplasty with transampullary septectomy has 
been well standardized over the last two decades and is designed to 
provide adequate drainage of both bile and pancreatic juice. The 
original procedure included division of the entire length of the sphincter 
of Oddi with suturing of the mucosa of the duct to the duodenal 
mucosa to prevent narrowing to the opening and subsequent 
extravasation of biliopancreatic secretions (Jones et al 1969). This 
technique was improved by the addition of septectomy (Nardi et al 
1966, Nardi et al 1983) and then with use of a carbon dioxide laser 
(Davis 1988). There are theoretical advantages of the surgical 
procedure over endoscopic sphincterotomy. Biliary endoscopic 
sphincterotomy generally does not affect the transampullary septum. 
The transampullary septum if inflamed or fibrotic may block the outflow 
of bile or pancreatic juices with resulting obstruction (Moody et al 
1983). Although there are reported successful endoscopic septotomy 
(Fuji et al 1989, Grimm et al 1989). A study by Moody et al 1990 
reported that septotomy is beneficial as twelve of seventeen patients 
with previously unsuccessful but adequate sphincteroplasty obtained pain 
relief after excision of the septum. The second advantage of surgical 
therapy over endoscopic is that a mucosa to mucosa apposition can 
be obtained. This is important in avoiding further scarring and 
restenosis of the ampulla (Moody et al 1990 and Watanapa et al 
1992). The risk from complications of surgical sphincteroplasty is 2% 
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(Negro et al 1984). Even with the lower complication rate, surgical 
sphincteroplasty is not commonly performed in the United Kingdom and 
endoscopic sphincterotomy dominates. 
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1.5.3 Endoscopic stenting 
Endoscopic stenting has been shown to lower common bile duct 
pressure significantly in animal studies and has been proposed as 
immediate therapy for the treatment of sphincter of Oddi dysfunction 
(Youngelman et al 1997). However while sphincter of Oddi patients do 
benefit in terms of symptomatic relief following biliary stenting there is 
an unacceptably high incidence of pancreatitis (38%) (Goff et al 1995) 
and this method is therefore not recommended. No studies have 
assessed the role of pancreatic stenting alone for pancreatic sphincter 
dysfunction. I 
1.5.4 Endoscopic balloon sphincteroplasty. 
This technique involves positioning an "Olbert" balloon into the 
sphincter over a guidewire and then inflating the balloon to 10mm or 
15mm for 1 minute. This procedure may be repeated to ensure 
adequate dilatation and muscle disruption. Many regard endoscopic 
balloon sphincteroplasty as an unsafe procedure for the treatment of 
sphincter of Oddi dysfunction (Kozarek et al 1988) due to the high rate 
of pancreatitis but really the evidence is not conclusive. Recent studies 
show that endoscopic papillary balloon dilatation is safe in patients with 
common bile duct stones, with a lower complication rate than 
endoscopic sphincterotomy (Sato et al 1997, Bergman et al 1997 and 
Mathuna et al 1995). Sato showed that balloon dilatation effectively 
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lowers sphincter basal pressure. Balloon sphincteroplasty has also been 
shown to be of therapeutic benefit in patients with biliary sphincter 
stenosis (MacMathuna et al 1983). Further studies are required to 
evaluate the efficacy of endoscopic balloon sphincteroplasty in the 
treatment of sphincter of Oddi dysfunction before a conclusive opinion 
can be determined. 
1.5.5 Local injection of Botulinum Toxin. 
Botulinum toxin A works as a potent inhibitor of the release of 
acetylcholine from nerve endings, by inhibiting calcium dependent 
release of acetylcholine, an effect mediated by the enzymatic cleavage 
of the synaptic vesicle protein SNAP-25 (Simpson et al 1981, Blasi et 
al 1993). It is an effective treatment for disorders of skeletal muscle 
spasm such as blepherospasm (Jankovic et al 1991). More recently it 
has been used in the gastrointestinal tract (Parisha et al 1994) to treat 
achalasia by lowering sphincter pressure. The therapeutic benefits are 
rather variable (Bhutani et al 1997). In animal studies Botulinum A toxin 
effectively lower sphincter basal pressure for up to 28 weeks and so is 
unlikely to provide long-lasting symptomatic relief . The first 
description 
of its use for sphincter of Oddi dysfunction was in 1994 by Parischa et 
al. In two patients with sphincter of Oddi dysfunction there was 
effective lowering of sphincter basal pressure but neither sustained 
symptomatic benefit despite these objective findings. In a prospective 
study of patients with type 3 sphincter of Oddi dysfunction only 50% of 
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the patients showed symptomatic improvement at six weeks (Wehrmann 
et al 1998), but such patients do not to benefit from endoscopic 
sphincterotomy either (Thatcher et al 1987). Botulinum toxin may 
provide a safe and useful tool to determine which patients are likely to 
benefit from endoscopic sphincterotomy (Muehidorfer et al 1997) 
Non invasive -medical therapy 
1.5.6 Nifedipine 
Nifedipine is a calcium channel antagonist which inhibits the movement 
of calcium into cells through voltage sensitive channels in the cell 
membrane. As with Botulinum toxin, it is used elsewhere in the 
gastrointestinal tract where there is failure of a sphincter to relax, such 
as the lower oesophageal sphincter in achalasia. Initial animal studies 
in the opossum showed that nifedipine reduces sphincter of Oddi 
motility (Coelho et al 1987). Simon and Kovacs in 1983 reported the 
first clinical use of nifedipine in patients with sphincter of Oddi 
dysfunction, four patients responded with an excellent clinical response, 
seven with a good response and three of fourteen with a poor 
response. A subsequent study using Nifedipine 20mg sublingually was 
shown to reduce sphincter basal pressure in normal healthy volunteers 
and in patients with sphincter of Oddi dysfunction (Guelrud et al 1988). 
A well designed prospective study (n=28) has shown that nifedipine is 
effective therapy in a selected group of patients with sphincter of Oddi 
dysfunction, those with elevated basal pressure and phasic contractions 
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that are mainly in an antegrade direction (Khruoo et al 1992). No long- 
term study has been performed to assess the efficacy of Nifedipine 
therapy or to assess its effectiveness in indicating subsequent response 
to endoscopic sphincterotomy. 
1.5.7 Nitrates 
Nitrate therapy was first proposed as an alternative medical therapy for 
sphincter of Oddi dysfunction in 1983 (Bar-Meir et al 1983). Nitrates act 
as nitric oxide donors which relaxes the sphincter of Oddi in man and 
animals with category 2 resistor like sphincters. (Gocer 1994, Luman 
1997 and Sand 1997). Velosy et al 1997 found in nine female patients 
with suspected sphincter of Oddi dysfunction that glyceryl trinitrate 
effectively normalised the quantitative parameters of the prostigmine- 
morphine test in these patients. No prospective studies have been 
performed to look at the efficacy of nitrate therapy in patients with 
raised basal sphincter at endoscopic manometry. 
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1.5.8 Transcutaneous nerve stimulation 
Transcutaneous nerve stimulation has been shown to reduce lower 
oesophageal pressure in patients with achalasia with an associated rise 
in levels of plasma vasoactive intestinal peptide. As has previously 
been discussed this neuropeptide is in abundance in the human 
sphincter of Oddi. Transcutaneous nerve stimulation has been assessed 
for the treatment sphincter of Oddi dysfunction in one study which 
showed a reduced sphincter basal pressure in patients with sphincter 
dysfunction but not in healthy volunteers. (Guelrud et al 1991). 
In summary endoscopic and surgical sphincterotomy are effective 
modalities in patients with biliary type 1 and 2 sphincter of Oddi 
dysfunction. To date no satisfactory long-term outcome has been 
achieved with these therapies. Balloon sphincteroplasty has a bad 
reputation but further studies need to be performed. Botulinum toxin is 
an interesting technique but one which is unlikely to be a curative 
procedure. Nifedipine is the only medical therapy to have been 
evaluated systematically and may be suitable therapy for a select group 
of patients although no long-term outcome studies have been 
performed. Further studies are required before nitrates or trancutaneous 
nerve stimulation can be recommended. but may be used to determine 
responsiveness to future sphincterotomy. Pancreatic sphincter 
dysfunction may respond to biliary sphincterotomy, but there is little 
data on the outcome following pancreatic sphincterotomy. No medical 
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therapy has been investigated for the treatment of disorders related to 
pancreatic sphincter dysfunction. 
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Chapter 2 
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THE AIM 
2.1 Introduction 
The current state knowledge of sphincter of Oddi function and 
dysfunction have been discussed in chapter 1, and it is evident from 
this that there are many aspects of sphincter of Oddi physiology that 
are still unclear. The mechanism by which sphincter dyskinesia occurs 
with the gallbladder in situ or after cholecystectomy is not known. 
Sphincter of Oddi function in many animals has been studied, but there 
is limited data that can be extrapolated to man as many of the models 
used are animal with type 1 (pump-like) sphincters. The action of the 
many neuropeptides located within the sphincter of Oddi are not 
known, and the methods used for the measurement of sphincter of 
Oddi motility are not ideal in that they only provide a snap shot of 
sphincter activity. The measurements made with the present "gold 
standard" perfused catheter give the pressure profile of the sphincter at 
only two points and thus the presence and role of sphincter symmetry 
or asymmetry has not been adequately established. 
The geographical distribution of the groups investigating the sphincter of 
Oddi illustrate the countries which recognize the existence of sphincter 
of Oddi dysfunction. In America, Japan and Australia sphincter of Oddi 
manometry is a common procedure in patients undergoing endoscopic 
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retrograde cholangio-pancreatography. There is some interest in France 
but little interest in this field within the United Kingdom. 
2.2 Aims 
1. To develop a suitable anaesthetic regime that does not interfere 
with sphincter of Oddi motility. (chapter 4) 
2. To test the hypothesis that cholecystectomy leads to an alteration in 
neuro-humoral response of the sphincter of Oddi and in so doing 
develop an animal model of sphincter of Oddi dysfunction. (chapter 
5) 
3. To investigate the action of substance P on the porcine sphincter of 
Oddi in vivo and in vitro. (chapter 6) 
4. To develop a new 8 channel catheter with a view to performing 
vector manometry of the sphincter of Oddi (chapter 7) 
5. To audit the manometric measurements, diagnosis and outcome of 
consecutive patients studied at the Royal London Hospital. (chapter 
8) 
6. To determine the occurrence and relationship of tachyoddia and the 
duodenal migrating motor complex. (chapter 9) 
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CHAPTER 3 
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THE DEVELOPMENT OF A SUITABLE ANIMAL MODEL FOR THE 
INVESTIGATION OF SPHINCTER OF ODDI FUNCTION 
3.1 Introduction 
The use of animals for medical research involves many ethical issues 
and moral dilemmas, covered by both British and European Law, the 
Home Office being the governing body within the United Kingdom. Prior 
to any animal experimentation I completed modules one to five of the 
Animal Scientific Procedures Courses and a Large Animal Section to 
cover working with pigs. A Project Licence and relevant Personal 
Licence were granted by the Home Office for the studies carried out in 
chapter four, five six and seven and a relevant personnel license. 
Techniques cannot be practiced on any animals outside those included 
in the project. The personal licence also strictly defines each procedure 
that an individual is certified to perform. 
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To investigate a specific hypothesis in an animal model and to then 
extrapolate the findings and hence draw conclusions about man is 
regarded with caution. It is however often ethically and practically 
impossible to perform some studies in man. The development of 
suitable animal models which are representative of human physiology or 
disease are required to facilitate research. Animal models have been 
developed for the investigation of many aspects of gastrointestinal 
physiology and pathophysiology.. 
A number of considerations must be made in the development of an 
animal model that is representative of the human sphincter of Oddi: 
1. The sphincter must respond in a similar way to hormones, 
primarily cholecystokinin. 
2. The neuropeptide innervation must be representative of the 
human sphincter. 
3. The anatomy should resemble the human anatomy to allow the 
development of new devices to measure sphincter pressure before 
use in man. 
A large number of species have been used in the investigation of 
sphincter function including: the opossum, possum, guinea-pig, cat, dog 
and pig. Some species such as the rat and pocket gopher do not have 
gallbladders and have a rudimentary sphincter of Oddi, they are not 
therefore suitable models (Hallenbeck et al 1967). 
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3.1.1 The opossum and possum. 
The opossum and possum have been widely used for in vitro (Baker 
et al 1992, Baker et al 1993 Simula et al 1997) and in vivo (Toouli et 
al 1981, Becker et al 1982, Toouli et al 1983, Parodi et al 1988, 
Takashashi et al 1988, Liu et al 1993) experiments for the investigation 
of sphincter of Oddi function. Unlike man, the opossum sphincter of 
Oddi is largely extraduodenal and the bile and pancreatic ducts join to 
form a common channel of entry into the duodenum. In the American 
opossum circular muscle encircles both ducts while in the Australian 
species the arrangement is that of a figure-of-eight. The extraduodenal 
position of the sphincter lends itself to easy access for resection, use 
in vitro, and also for electromyographic (Honda et al 1982, Takahashi 
et al 1984) experimentation. The opossum and possum sphincters 
respond in an excitatory manner to cholecystokinin (Becker et al 1982, 
Honda et al 1983) and are therefore type 1- pump like sphincters 
(Calabuig et at 1990). The response to caerulein, motilin, and 
pentagastrin is excitatory and therefore differs from that of man, 
whereas there are similar responses to man with other neuropeptides 
such as acetylcholine (excitatory), glucagon (inhibitory) and secretin 
(inhibitory) (Coehlo et al 1985, Helm et al 1989). 
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3.1.2 The guinea-pia 
The guinea-pig sphincter anatomy is similar to man in that the bile 
duct and pancreatic duct enter a common ampulla which is situated 
within the duodenal wall. Little is known of many of the gastrointestinal 
hormonal actions on the guinea-pig ' sphincter but it does appear to 
relax in response to cholecystokinin and is a type 2, resistor like 
sphincter. Nitric oxide donors have been shown to relax the sphincter 
as in man (Gocer et al 1994). Interestingly a recent study has shown 
that cholecystectomy raises sphincter of Oddi opening pressure 
(Carvajal et 1994). The guinea-pig does appear to be a valid small 
animal model for sphincter of Oddi function" pressure but measurements 
cannot be made using the same apparatus as in man. 
3.1.3 The cat 
The anatomy of the cat resembles man with both bile duct and 
pancreatic ducts joining together in a short common channel which is 
surrounded by a sphincter that lies largely within the wall of the 
duodenum. The cat sphincter is a type 2 sphincter- (Dahlstrand et al, 
1990). Enkepahalin receptors act to contract the sphincter (Thune et al 
1992) and motilin reduces sphincter of Oddi flow by increasing its 
motor activity (Behar et al 1988). The cat is a suitable model but 
again is limited by its small size relative to the methods of pressure 
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measurements and also by the ethical constraints in the United 
kingdom because this species is a "pet". 
3.1.4 The do 
The anatomy of the dog differs from man with the pancreatic and bile 
ducts entering the duodenum separately but in close proximity; as with 
humans the sphincter lies within the wall of the duodenum. The dog 
sphincter exhibits a two-fold response to exogenous cholecystokinin; 
firstly, a contractile effect, probably mediated through a direct myogenic 
action and neural release of acetylcholine; secondly a relaxant effect, 
probably mediated by stimulation of postganglionic neurons (Pozo et al 
1990). Motilin has been shown to contract the canine sphincter (Neya 
et al 1981). The dog is of a sufficient size that endoscopic 
measurement of the sphincter pressure is possible by means of a 
perfused or microtransducer catheter (Deng 1996) and has been used 
to investigate the interrelationship of the gallbladder, sphincter of Oddi 
and the duodenal migrating motor complex (Yokahata 1994, Funch- 
Jensen 1991). There are very strict criteria for the use of domestic 
animals for experimentation in Great Britain. Dogs must be obtained 
from licensed breeding establishments incurring considerable costs which 
often precludes their use. 
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3.1.5 The porcine model 
The porcine sphincter anatomy is similar to the dog, and differs from 
man, the bile and pancreatic ducts opening separately into the 
duodenum. The biliary sphincter is located within the duodenal wall as 
in man, and opens in the first part of the duodenum. The pancreatic 
sphincter and opening is located approximately 10-15cm distal to the 
biliary sphincter. The porcine biliary sphincter of Oddi is a type 2 
sphincter and relaxes in response to cholecystokinin (Pasricha et al 
1995). The neural network in the porcine biliary sphincter closely 
resembles that in man with the a similar group of neuropeptides 
represented (fig. 12) (Harling et al 1991, Sand et al 1993, Sand et at 
1994, Sand et al 1997). Despite the differences in anatomy the porcine 
model has been proposed as a unique endoscopic model for teaching 
and research. It is possible to pass a duodenoscope and cannulate 
both the biliary and pancreatic ducts (Pasricha 1995). 
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Fig. 12 Immunoreativity observed in nerves of pig sphincter of 
Oddi, gallbladder, common bile duct. and duodenum 
Duodenal 
Mucosa 
Sphincter 
of Oddi 
Gallbladder Common 
Bile duct 
VIP ++++ ++++ ++ ++ ++ 
NPY +++ +++ +++ 
Galanin +++ +++ ++ ++ +++ 
PHI ++ ++ + ++ ++ 
Bombesin + + + ++ 
Sub P+ ++ + + 
Serotonint -- (+) --(++) __ _ (++) 
Somatostatint-- (+) ý(++) __ __ (+++) 
Immunoreativity grading ++++ verystrong, +++ strong, ++ moderate, + 
borderline, -- no observed immunoreactivity. t Immunoreactivity for 
serotonin or somatostatin was not observed in the nerves, but instead 
in the epithelium of the sphincter of Oddi, gallbladder, and duodenum, 
although no in the epithelium of common bile duct. NPY: neuropeptide 
Y, Sub P: substance P, PHI: peptide histidine- isoleucine, CGRP: 
calcitonin gene-related peptide. 
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In summary the cat, dog and pig appear to be suitable large animal 
models for investigating sphincter of Oddi function. The cat cannot be 
investigated endoscopically or with the catheters used for human 
studies. The use of the cat and dog for medical experimentation is 
strictly controlled and the animals are only available from licensed 
centers at considerable expense. Pigs may be purchased for medical 
research from any farm source and are therefore economically 
attractive. However as with all animal experiments the Home Office sets 
stringent limits to the number of animals that can investigated. 
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3.2 EXPERIMENTAL METHODS 
3.2.1 Animals 
Adolescent large white pigs (Sus-scrofus domesticus) initially weighing 
between 20-30kg were studied. The pigs were supplied by the Royal 
Veterinary College, Hertfordshire. The animals were housed within an 
authorised specialized large animal unit. The pigs were fed a standard 
dry food diet twice daily and occasional apples. Daily husbandry was 
carried out by animal technicians and I visited the animals most days. 
3.2.2 Cholecystectomy 
The animals were anaesthetized with a combination of halothane, 
nitrous oxide and oxygen after a twelve hour fast. Sterile gloves, 
gowns and instruments were used. Using an aseptic technique the 
abdomen of each animal was prepared with betadine. A Kocker s right 
subcostal incision was made through the skin. The muscle layers were 
incised using cutting diathermy and spread manually to expose the 
peritoneum. The peritoneum was grasped with forceps and careful 
palpation made to ensure that no loops of bowel were lying 
superficially before entry was made into the peritoneum with a scalpel. 
The liver and gallbladder were then easily identified. Packs were used 
to displace the bowel away from the liver. The gallbladder fundus was 
grasped with forceps and carefully retracted. The gallbladder was then 
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dissected from the liver bed using sharp and blunt dissection 
techniques. Haemostasis was maintained using coagulating diathermy. 
When the gallbladder was free from the liver and Cabot's triangle was 
easily identified, the cystic duct and cystic artery were ligated and cut. 
A full inspection of the gallbladder bed and ligatures were made prior 
to closure of the wound. The peritoneum and abdominal muscles were 
closed in layers using 2/0 Vicryl, sutures (Ethicon Ltd., U. K. ). The skin 
was then closed using single subcutaneous 2/0 Ethilon suture (Ethicon 
Ltd., U. K. ). Finally the wound was infiltrated with 2% lignocaine local 
anaesthetic to provide local post operative pain relief as commonly 
used in man. On recovery the animals were immediately mobile and 
hungry. Post operative antibiotics (intramuscular twice daily Cefuroxime 
750mg, Galaxo pharmaceuticals) were given for forty-eight hours. 
3.2.3 Sham Laparotomy 
Each pig was starved for 12 hours and then anaesthetised as above. 
A Kocker's incision was made, the muscle layer and peritioneum were 
divided. The gallbladder and liver were identified. The gallbladder was 
manually manipulated for five minutes and the wound was closed as 
above. The animal was allowed to recover and given post operative 
antibiotics for forty-eight hours (intramuscular twice daily Cefuroxime 
750mg, Galaxo pharmaceuticals). 
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3.2.4 Standard sphincter of Oddi manometry 
Manometry was either performed endoscopically or via a duodenotomy. 
A triple lumen Lehman catheter (Wilson-Cook, USA) was used as 
shown in plate A. The catheter has a central channel and two 
recording channels. Ten lines, 2mm apart are marked on the catheter 
tip to facilitate the station pull through. The two measuring channels 
open 2mm in distance and 180 degrees apart at the red marks seen. 
The catheter was perfused using a low compliance Arndorfer 
pneumohydraulic pump ( mean pressure 0.2 bar) as shown in plate E. 
Water was perfused at a rate of approximately 0.1 ml/minute per lumen. 
The external pressures transducers were connected to the catheter via 
anaesthetic connection tubing. The pressures transmitted proximally to 
external transducers were record by a computer system. The recordings 
were displayed and analyzed using a modified oesophageal manometry 
program (Phoenix, U. K. ). 
During the prolonged studies described in chapter four, five and six the 
sphincter high pressure zone was located by a pull-through manometry. 
The catheter was then positioned in the mid point of the high pressure 
zone and sutured to maintain this position. Baseline control and 
pharmacologically stimulated studies were performed. 
Pharmacological dynamic studies were performed using cholecystokinin- 
octapeptide (Sigma chemicals) and Morphine sulphate. Cholecystokinin- 
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octapeptide was infused intravenously at a rate of long/kg/min. 
Although this flow rate produces supra-physiological plasma levels, 
similar doses have been used to investigate gallbladder and sphincter 
of Oddi motility in other species (Grace et al 1987, Muller et al 
1987, Cox et al 1990, Hanyu et al 1990, Pozo et al 1990, Richard et 
al 1993, Elbrond et al 1994, Muller et al 1987, Chen et al 1997). An 
infusion period of 30 minutes was used to allow gallbladder emptying 
to occur and to enable equilibrium of sphincter of Oddi motility. 
Analyses were made of the data obtained over the final ten minutes of 
each infusion. 
Morphine Sulphate stimulates contraction of the human sphincter of 
Oddi (Madura et al 1981, Nardi et al 1983) but its action on the 
porcine sphincter of Oddi is not known. A bolus dose of 5mg Morphine 
sulphate was given intravenously and observations recorded for five 
minutes in each study. 
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PLATE E: THE ARNDORFER PNEUMOHYDRALIC PUMP AND 
COMPUTER SYSTEM 
The phoenix computer manometry system 
ýý 
3.2.5 Bench test: The dynamics of the Lehman triple lumen catheter 
Ideally all manometric systems should be capable of recording absolute 
values of the pressure wave with accuracy . Both pressure rise rates 
and baseline offset are indicators of catheter fidelity (Omari et al 1996, 
Chen et al 1998). 
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The Arndorfer pneumohydraulic pump 
Bench studies were performed to determine the fidelity of two five 
french diameter triple lumen Lehman catheters. Flow rates were also 
measured with different pressures and calibration studies were 
performed. 
The baseline pressure offset was measured for perfusion pressures of 
0.1 bar, 0.2 bar and 0.3 bar. The mean baseline pressure offset for 
the anaesthetic extension tubing which connected the catheter to the 
pressure transducers was 1 mmHg at all perfusion pressures. The 
pressure offset for two Lehman triple lumen catheters was measured 
by calibrating the system including the anaesthetic extension tubing to 
air and zeroing level to the pressure transducers, a primed catheter 
was then connected to the anaesthetic extension tubing and the 
pressure recorded was taken as the baseline pressure offset. The 
baseline pressure offset for the two Lehman catheters is shown in 
figure 13. 
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Fig. 13 The baseline pressure 
offset for two Lehman catheters 
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The pressure rise rate was determined for two Lehman catheters with 
perfusion pressures of 0.1,0.2 and 0.3 bar by manual occlusion of the 
measuring ports three times to a pressure of 100mmHg above 
baseline. 
The pressure rise rates were calculated and expressed in mmHg sec' 
and are shown in figure 14. 
Fig 14 Pressure rise rate 
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Both the baseline offset and the pressure rise rate rose almost linearly 
with increased perfusion pressures. In order to achieve accurate 
pressure measurements within the sphincter of Oddi the pressure rise 
rate must be sufficient to record peak amplitude. This criteria is 
determined by the equation below 
Pressure rise rate > 10 ( amplitude x frequency of the waves to be 
measured) 
For the sphincter of Oddi this would mean be : 
Pressure rise rate > 10 (195 x 6/3600) = 3.25mmHg sec'' 
Therefore at all perfusion pressures this is achieved. 
Baseline offset is also a determinant of manometric fidelity and 
reliability of recordings. High baseline offsets augment the degree of 
baseline fluctuations that occur with minor changes in reservoir pressure 
that are characteristic of pneumohydraulic pump systems. High baseline 
offsets also reduce the pressure differential between the manometric 
assembly and the transducer; this attenuates the net perfusion rate and 
hence the pressure rise rate and therefore fidelity. Baseline offset 
pressures less than 50mmHg are acceptable for the measurement of 
the lower oesophageal sphincter and the sphincter of Oddi (Chen et al 
1998). 
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The flow rate was measured for perfusion pressures of 0.1,0.2 and 0.3 
bar by collecting the perfusate over a five minute period and the 
results are shown in figure 15 below. 
Fig. 15 Flaw rates for a given 
prefusion pressure 
0.3 
0.25 
0.2 
30.15 
G) 
0.0.1 
aD 
L 
3 0.05 
0 
0 
0 0.2 0.4 
Perfusion pressure (bar) 
ýI Catheter Al 
Catheter B 
101 
Finally calibration studies were performed for the same perfusion 
pressures with the Lehman catheter connected to a sealed system 
incorporating a sphygmomanometer. The results of these studies are 
shown in figures 16,17 and 18. The measured pressure matched the 
actual pressure in nearly all cases. 
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Fig. 17 Calibration of the 
Lehman catheter with a 
perfusion pressure of 0.2 bar 
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Lehman catheter with a 
perfusion pressure of 0.3 bar 
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In the experiments performed below a perfusion pressure of 0.2 bar 
was used because high perfusion flow rates resulting from high 
perfusion pressures have bee shown to increase the risk of procedure 
related pancreatitis (Meshkinpour et al 1992). At this pressure the 
above bench studies show that there is an acceptable baseline offset 
and pressure rise rate to measure human and porcine sphincter of 
Oddi pressures. The catheter was shown to accurately measure known 
pressures 
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3.3 Statistical methods 
The experiments contained in this thesis generated a large amount of 
numerical data. In order to make valid statements on the groups and 
comparisons between groups, appropriate statistical analysis was used. 
Data can be divided into two major types: one in which the data 
conforms to a "normal" distribution (where "normal refers to a 
mathematical description of the data defined by its mean and standard 
deviation), and the other in which the data is not "normally" distributed. 
For "normal" data parametric statistical test are appropriate, whereas for 
"non-normal" data non-parametric tests must be used. 
When repeated measurements of the same parameters were made on 
the same animals following different stimulus, and for analysis of 
physiological data the paired t-test was employed, with each subject 
acting as his own control. 
Where comparisons were made of the results from different animals 
(sham group versus cholecystectomy group) non parametric methods 
were employed. For each parameter, the median, range and 
interquartile ranges were calculated and the Mann-Whitney U test 
employed to assess changes in baseline recordings and 
pharmacological stimuli. The Fisher's exact test was used to compare 
the patients with tachyoddia in chapter nine. 
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In all the statistical tests a level of 5% or less was used to indicate 
statistical significance, though due weight was also given to results 
approaching but not meeting that cut-off. 
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Chapter 4 
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ANAESTHESIA FOR PORCINE SPHINCTER OF ODDI MANOMETRY. 
4.1 Introduction 
Human sphincter of Oddi manometry is commonly performed under 
sedation only. The commonest agents used are the benzodiazipines: 
diazepam or midazolam, which do not interfere with or alter sphincter 
of Oddi motility (Garcia et al 1988, Cuer et al 1993). Unfortunately it is 
not possible to perform sphincter of Oddi manometry in large animal 
studies under sedation. It is not thought appropriate by the Home 
Office in view of the nature of the procedure. In addition the 
endoscopic equipment is costly and could be easily damaged if a 
lightly sedated animal were to bite down onto the endoscope. In view 
of this it is necessary to perform manometry on animals that are under 
general anaesthesia. 
It is important that the effect of the anaesthetic agents used do 
not interfere with sphincter motility. There is little known about the 
action of halothane on type 2 animals. Only one study to date has 
looked at the possible effects of halothane on the sphincter of Oddi, in 
the Australian possum, a type 1 pump like sphincter. In this study 
trans-sphincteric flow was measured as the indicator of sphincter tone, 
it was found that halothane reduced trans-sphincteric flow in a dose 
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dependent manner, suggesting that halothane caused an increase in 
sphincter of Oddi tone (Lui et al 1993). 
4.2 Aim 
The aims of this study were to determine the effects of two commonly 
used anaesthetic agents (halothane and enflurane) on porcine sphincter 
of Oddi motility. 
4.3 Method 
4.3.1 Pilot Study 
Two adolescent pigs (Sus-scrofus domesticus) which had previously 
undergone a sham laparotomy 8 weeks before were studied. The first 
animal was anaesthetised with a combination of halothane 2-5%, 
nitrous oxide and oxygen, it was then intubated and anaesthesia 
maintained with the same combination of gases. The second animal 
was induced using a combination of midazolam, enflurane, nitrous oxide 
and oxygen. Enflurane is not an easy agent for induction of 
anaesthesia because it causes respiratory irritation, therefore Midazolam 
was used to provide adequate depth of anaesthesia for intubation. In 
both animals sphincter of Oddi manometry was performed through a 
duodenotomy. A baseline sphincter of Oddi pressure recording was 
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made for 30 minutes. Then cholecystokinin (Sigma chemicals, U. K. ) 
long/kg/min was infused for thirty minutes with continuous monitoring. 
The baseline basal pressure, wave amplitude and wave frequency were 
compared between both animals and with published data. (Sand et al 
1997). 
4.3.2 Main study 
Four pigs were studied, they had either undergone previous sham 
laparotomy (n=2) or cholecystectomy (n=2) as described in chapter 3. 
Induction and subsequent maintenance of anaesthesia was initially with 
an enflurane, midazolam, nitrous oxide, oxygen combination. 
Sphincter of Oddi manometry was performed through a duodenotomy. 
Each animal followed this schedule of recordings: - 
1. Baseline recordings for 15 minutes. 
2. Cholecystokinin long/kg/minute was infused for 30 minutes. 
3. Washout period of 15 minutes. 
4. Baseline recordings for 5 minutes. 
5.5mg of morphine sulphate was then given intravenously and 
recordings made for 5 minutes. 
6. Washout period of 15 minutes. 
7. Enflurane was stopped and halothane 2-5% commenced, 
recordings taken for 15 minutes. 
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8. Morphine sulphate 5mg given intravenously and recordings taken 
for a final 5 minutes. 
4.4 Statistical methods 
The results were analysed comparing the last ten minutes of the 
baseline recordings when a steady state was observed and the five 
minutes after morphine sulphate injection. Therefore the data is 
matched because it arises from the same animal statistical analyses 
were performed using the paired t test. 
4.5 Results 
4.5.1 Pilot study 
The sphincter of Oddi of the pig anaesthetised with halothane 
appeared to be completely relaxed with no basal pressure, no evidence 
of phasic activity and no change in activity during or following the 
infusion of cholecystokinin. The pig anaesthetised with enflurane/ 
midazolam had a sphincter of Oddi basal pressure of 10mmHg, the 
sphincter also showed phasic activity, with a wave frequency was 
I cycle/ minute with an amplitude of 5mmHg. 
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4.5.2 Main study 
The results are displayed (fig. 19) as mean values (standard error of 
the mean) and graphs overleaf (figures 20 and 21). The motility index 
was calculated as the result of frequency multiplied by the amplitude. 
Halothane significantly reduced sphincter of Oddi response to morphine 
sulphate stimulation compared with enflurane anaesthesia (basal 
pressure rise of 5.8mmHg under enflurane compared with a fall of 
1.2mmHg under halothane (p=0.029), motility index: rose by 23.7 
mmHg/ c/min under enflurane compared with a rise of 6.2 mmHg/c/min 
under halothane anaesthesia (p=0.098)). Sample recordings after 
morphine sulphate using enflurane and halothane anaesthesia are 
shown in Plates F and G respectively. Although halothane also appears 
to reduce sphincter of Oddi resting basal pressure and motility the 
differences did not reach statistical significance (basal pressure 
3.5mmHg under halothane compared with 4.2mmHg under enflurane 
anaesthesia (p=0.59), motility index OmmHg/min under halothane 
compared with 4.7mmHg/min under enflurane (p=0.095)). 
Regular phasic activity (frequency 1 cycle/min, amplitude 4.7 mmHg) was 
observed whilst under anaesthesia with enflurane. 
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Fig. 19 The effect of the anaesthetic agent on sphincter 
of Oddi motility 
Basal Pressure (mmHg) Motility index 
Pre 
Morphine Morphine Pressure 
Pre 
Morphine Morphine Change 
Sulphate Sulphate Change Sulphate Sulphate 
Enflurane 
+ 4.2 10.5 5.8 4.7 28.5 23.7 
Midazolam (2.921 (2.321 (1.60) (1.97) (5.68) (7.24) 
Halothane 
3.5 2.2 -1.2 0 6.2 6.2 
Midazolam 
(1.93) (0.85) (1.93) (0) (2.83) (2.83) 
p value 
paired t 0.59 0.062 0.029 0.095 0.028 0.098 
test 
113 
Fia 20 THE EFFECT OF ENFLURANE/ HALOTHANE 
15 
ANAESTHESIA ON BASAL PRESSURE 
Pre 
Morphine Morphine 
Sulphate Sulphate 
p=0.59 p=0.062 
" 
" 10.2 
10 
" 
0 
5 
" 
4.2 " 
" 
" 
3.5 " 2.2 T 
"" 
Enflurane Halothane Enflurane Halothane 
& & & & 
midazolam midazolam midazolam midazolam 
114 
Fig 21 THE EFFECT OF ENFLUANE /HALOTHANE 
ANAESTHESIA ON THE MOTILITY INDEX 
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PLATE F: PORCINE MANOMETRY UNDER ENFLURANE AND 
MIDAZOLAM ANAESTHESIA 
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PLATE G: PORCINE MANOMETRY UNDER 
HALOTHANE AND MIDAZOLAM ANAESTHESIA 
4.6 Discussion 
This study shows that halothane and enflurane have different effects on 
sphincter of Oddi motility. This difference may be a direct one on the 
sphincter of Oddi alone or be a more generalised effect on intestinal 
motility. 
Enflurane does not appear to interfere with sphincter of Oddi motility, 
the baseline pressure recordings were comparable to that found by 
Sand et al 1997 (13.3 ±4 mmHg). Halothane appears to inhibit 
sphincter of Oddi activity. 
Animal studies have shown that sphincter of Oddi activity closely 
follows the phases of the migrating motor complex of the duodenum 
with maximum activity during phase 3 of the migrating motor complex 
(Yokohata et at 1994). In rats halothane has been shown to reduce or 
even abolish duodenal phase 3 activity whereas enflurane was found to 
have no effect on phase 3 activity but did reduced phase 2 activity 
(Wright et al 1982) halothane also reduces antral contractility the 
frequency of contractions in phase 3 of the duodenal migrating motor 
complex in man (Schurizek et al 1989). Certain drugs such as morphine 
sulphate can be used to induce premature phase 3 activity (Yokahata 
et al 1994) of the duodenum. In this study morphine sulphate induced 
sphincter of Oddi phasic activity under enflurane anaesthesia but there 
was little change in sphincter of Oddi activity under halothane 
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anaesthesia. Halothane suppressed the induction of phase 3 activity, as 
it does in rats and man, this effect is likely to be part of a more 
generalized effect on gut motility rather than specifically directed at the 
sphincter of Oddi. Halothane is therefore not a suitable agent for the 
induction or maintenance of anaesthesia in animal studies of sphincter 
of Oddi motility. 
Five percent of patients require general anaesthesia to undergo 
endoscopic retrograde cholangiography or sphincter of Oddi manometry 
(Etzkorn et al 1998). In these cases, there is often of a history of 
substance abuse and thus a tolerance to sedatives. Halothane should 
be avoided if sphincter of Oddi manometry and enflurane would seem 
an acceptable alternative. Conversely for Endoscopic retrograde 
cholangio-pancreatography alone the reduction in antroduodenal and 
sphincter activity induced by halothane would be advantageous by 
relaxing the sphincter and theoretically easing cannulation of either 
duct. The effect of other volatile anaesthetic such as isoflurane have 
not been assessed in animal or human studies and therefore cannot at 
present be recommended. 
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CHAPTER 5 
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CHOLECYSTECTOMY AND THE NEURO-HUMORAL RESPONSE OF 
THE PORCINE SPHINCTER OF ODDI. THE DEVELOPMENT OF AN 
ANIMAL MODEL OF SPHINCTER OF ODDI DYSFUNCTION. 
5.1 Introduction 
As discussed in chapter 1 sphincter of Oddi dysfunction is a 
recognised complication of cholecystectomy and occurs in up to 20% of 
patients post-cholecystectomy (Henry 1983, Drossman 1993). It is not 
clear whether sphincter of Oddi dysfunction predates cholecystectomy or 
whether disruption of neural networks lead to some alteration in 
sphincter control (Grace et al 1987, Thune et al 1998). The disruption 
of connecting neural networks is believed to lead to an alteration in 
responsiveness to cholecystokinin (Grace et at 1987, Evans et al 
1995). 
Between seventeen and nineteen percent of patients with sphincter of 
Oddi dysfunction (41% with associated irritable bowel syndrome) exhibit 
a paradoxical response to pharmacological doses of cholecystokinin 
(Rolny 1986, Evans et al 1995). The actions of cholecystokinin on the 
gallbladder and sphincter of Oddi are complex and mediated by 
myogenic and neuronal receptors. There are at least two mechanisms 
of action on the gallbladder. Postganglionic cholinergic neurons are 
stimulated in the gallbladder and these can be blocked by atropine 
Behar et al 1980). Secondly direct stimulation of the gallbladder smooth 
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muscle occurs and this effect is unaltered by complete denervation with 
tetrodotoxin. The sphincter of Oddi is inhibited by cholecystokinin via 
the stimulation of postganglionic non -adrenergic, non cholinergic 
presumably nitric oxide inhibitory neurones. This action is inhibited by 
tetrodotoxin but not by atropine (Behar et al `1980, Behar et al 1987). 
A direct effect is also mediated by stimulating excitatory, receptors on 
the smooth muscle of the sphincter, this action is not inhibited by 
tetrodotoxin (Behar et al 1980). 
Three animal studies have been performed to look at the effect of 
cholecystectomy on sphincter function (Grace et al 1987, Thune 1988 
Carvajal et 1994). Grace et al assessed the effect in the prairie dog of 
cholecystectomy (n=10) compared with sham laparotomy (n=8). The 
prairie dog has a type 1 sphincter which contracts in response to 
cholecystokinin. Eight months after cholecystectomy there was no 
alteration in sphincter resting motility but the response to 
cholecystokinin and duodenal fat infusion were blunted in the 
cholecystectomy group. A study in cats also failed to show any 
difference in resting activity after cholecystectomy but found an 
abnormal failure of relaxation of the sphincter in response to 
cholecystokinin (Thune et at 1988). Carvajal et al 1994 reported a study 
in twenty male Hartley guinea-pigs (a type 2 sphincter) and found a 
significantly higher sphincter opening pressure in the cholecystectomy 
group (n=10) compared with the sham group (n=10). The manometric 
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recordings in all these studies were of short duration and not obtained 
by methods that are used in human studies. 
A single human study has been reported to date (Luman et at 1997). 
In this study of five patients with uncomplicated cholelithiasis, sphincter 
of Oddi manometry was performed before and six months after 
laparoscopic cholecystectomy. There was no change in basal sphincter 
of Oddi pressure or motility after cholecystectomy. However the 
dynamic response to cholecystokinin (a bolus intravenous injection of 
1 Ivy Dog unit/kg) was altered, with a failure to suppress phasic 
activity after cholecystectomy. The findings from this study are limited 
by the short duration of the manometric recordings , approximately 10 
minutes, also sphincter of Oddi dysfunction occurs in at most 20% of 
post cholecystectomy patients and therefore a study of such size is 
unlikely to show significant results. A larger study or even a repeat of 
this study would be difficult to perform for the ethical reason, that there 
a significant risk of pancreatitis after manometry making it unjustifiable 
to perform in patients that are symptom free. 
5.2 Aims 
The aims of this study were to determine : 
I. If porcine sphincter of Oddi resting pressures are altered by 
cholecystectomy using prolonged manometric measurements. 
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2. To assess the response to cholecystokinin and morphine sulphate 
provocation following cholecystectomy. 
3. To determine the action of morphine sulphate on the porcine 
sphincter of Oddi. 
4. To determine if the post cholecystectomy porcine model is a 
suitable animal model of sphincter of Oddi dysfunction. 
5.3 Methods 
Sixteen female adolescent large white pigs (Sus-scrofus domesticus) 
were studied, with a starting weight of 20-25kg. Eight pigs underwent 
sham laparotomy and eight underwent cholecystectomy as described in 
chapter 3. Eight weeks after the initial procedure each animal was 
anaesthetised using a combination of enflurane, midazolam, nitrous 
oxide and oxygen. Sphincter of Oddi manometry was performed using 
a perfused catheter via a duodenotomy as described in chapter 3. 
Pressure recordings and dynamic studies were performed according to 
steps I to 5 of the schedule described in chapter 4. 
5.4 Statistical methods 
The results were analysed to compare: 
1. The final ten minutes of the cholecystokinin infusion in each animal. 
2. The five minutes after morphine sulphate injection. 
Statistical analysis was performed using the Mann Whitney U and 
paired student's t test where appropriate 
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5.5 Results 
Two animals had to be terminated early (within two weeks of their 
initial laparotomy) due to deteriorating health from presumed porcine 
influenza. Post-mortem examination of these pigs revealed lung 
consolidation. Porcine influenza virus is endemic in domestic pigs and 
can lead to pneumonia and reduced fertility. 
5.5.1 Baseline results: Sham v cholecystectomy 
The baseline results illustrated below (figures 22,23 and 24) show the 
sham group; median basal pressure of 9mmHg (range 2-13mmHg), 
median amplitude of BmmHg (range: 0-17) and median wave frequency 
1 cycle/minute (range 0-5cycles/ minute), a typical recording is shown in 
plate H. The baseline results of the cholecystectomy group were not 
statistically different (by Mann Whitney U) with a median basal pressure 
of 10mmHg (range 3-20mmHg), wave amplitude of 4mmHg (range 0- 
16mmHg) and wave frequency of 1 cycle/minute (range 0- 
8cycles/minutf Fig 22 A comparison of the 
baseline basal pressures 
mmHg 
20 
15 
10 
5 
" Sham group 
9 Cholecystectomy group 
p=0.48 by Mann 
Whitney U test 
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mmHg 
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2 
Fig 23 A comparison of the 
baseline wave amplitude 
I Sham group 
j Cholecystectomy group 
p=0.24 by Mann 
Whitney U test 
Fig 24 A comparison of the 
baseline wave frequency 
" Sham group 
0 Cholecystectomy group 
p=1.0 by Mann 
Whitney U test 
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Plate H: Porcine sphincter of Oddi manometry 
Sham group: "Normal Values" 
Basal pressure- 9 mmHg (2-13) 
Wave amplitude- 8 mmHg (0-17) 
Wave frequency- 1 c/min (0-5) 
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5.5.2 Results of the response to cholecystokinin infusion. 
The effect on Basal pressure 
The typical response of a sham animal sphincter to cholecystokinin 
infusion is shown in plate I. The median basal pressure of the sham 
laparotomy group fell significantly (p=0.028 by paired t test), from 
9mmHg (25th-75th centiles; 5-9 mmHg) to 3mmHg (25th-75th centiles; 0- 
18mmHg) during cholecystokinin infusion (figures 25 and 26). The 
median basal pressure for the cholecystectomy group did not fall 
significantly (p=0.49 by paired t test), from 10mmHg (25 '-75th centiles; 
3-18mmh) to 9mmHg (25tn-75th centiles; 3-10mmHg). There was no 
significant difference (p=0.55 by Mann Whitney U test) in the pressure 
change between the two groups in response to cholecystokinin. 
Interestingly however two of the cholecystectomy group exhibited a 
paradoxical response to cholecystokinin with a rise in basal pressure 
and overall the inhibitory effect of cholecystokinin on basal pressure 
was less in the cholecystectomy animals. 
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Plate I: The response of the porcine sphincter of Oddi to 
cholecystokinin 
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Fig. 25 THE EFFECT OF CHOLECYSTOKININ INFUSION ON BASAL 
PRESSURE IN THE SHAM LAPAROTOMY GROUP 
mmHg 
25 
20 
test 
15 
10 
Pre CCK CCK 
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Fig 26 THE EFFECT OF CHOLECYSTOKININ INFUSION ON BASAL 
PRESSURE IN THE CHOLECYSTECTOMY GROUP 
mmHg 
25 
20 
paired t test 
15 
10 - 10 
S 
Pre CCK CCK 
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The effect on wave amplitude 
In response to cholecystokinin median wave amplitude fell in the sham 
group from 7mmHg (25th-75th centiles; 0-8mmHg) to l mmHg (25th-75th 
centiles; 0-4mmHg)( p=0.056 by paired t test) (fig. 27). The wave 
amplitude remained unaltered in the cholecystectomy group (pre 
4mmHg (25th-75th centiles; 0-10mmHg) and post 4mmHg (25tn-75th 
centiles; 3-8mmHg (p=0.61 by paired t test))(fig. 27). Cholecystokinin 
dampened the wave amplitude in the sham group more compared to 
the cholecystectomy group (change in wave amplitude (pre -post )for 
the sham group compared with the change in wave amplitude (pre- 
post) for the cholecystectomy group p=0.051 by Mann Whitney U test) 
Fia 27 The comparison of the 
mmHg 
20 
15 
10 
effect on wave amplitude 
Pre CCK Post CCK sham v 
amplitude sham v chole p=0.15 by 
chole p= 0.47 by Mann Whitney U 
Mann Whitney Uý test 
test 
7 
5 
4 4 
1 
Pre CCK CCK 
! Ley   Sham group 
Cholecystectomy group 
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The effect on wave frequency 
In response to cholecystokinin wave frequency for the sham group rose 
from a median of 2 c/min (0-3) to 3 c/min (0-4) (p=0.56 by paired t 
test) and in the cholecystectomy animals from 1 c/min (0-3) to 3 c/min 
(3-4) (p=0.50 by paired t test)( fig. 28). There was no difference in pre 
CCK wave frequency between the two groups (p=1.0 by Mann Whitney 
U test) and there was no difference in frequency post CCK (p=0.58 by 
Mann Whitney U test). There was also no difference in the change in 
frequency in response to CCK between the two groups (difference in 
pre-post CCK frequency for the sham group v pre-post CCK frequency 
cholecystectomy group p=0.79 by Mann Whitney U test). 
Fig. 28 The comparison of the 
effect on wave frequency 
C/min 
8 
6 
4 
2 
., _i n ., _n rig 
! jey . Sham group 
. Cholecystectomy group 
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5.5.3 Results of the response to morphine sulphate provocation. 
Two of the sham group were excluded from analysis because the 
catheter required relocation in the sphincter during the study and so 
the baseline and study measurements were not comparable. 
The effect on basal pressure 
The sphincter of Oddi in all animals was stimulated by morphine 
sulphate, a typical response is shown in plate J. The rise in basal 
pressure in response to morphine sulphate nearly reached significance 
in the sham group ( p=0.063 by the paired t test); a rise from 6mmHg 
(25 '-75th centiles; 2-12mmHg) to 12mmHg (25 h-75th centiles; 10- 
13mmHg)(fig. 29). The rise in basal pressure in the cholecystectomy 
group reached significance (p=0.026 by paired t test); a rise from 
9mmHg (25 h-75th centiles; 1-13mmHg) to 11 mmHg (25 '-75th centiles; 7- 
16mmHg)(fig. 30). The change in basal pressure in response to 
morphine sulphate for both groups was not significantly different (( 
sham pre-post basal pressure v cholecystectomy group pre-post basal 
pressure) p=0.86 by Mann Whitney U test) 
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Fig. 29 The effect of morphine sulphate 
on basal pressure in the sham 
laparaotomy group 
mmHg 
25 
20 
15 
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Pre Morphine 
Morphine sulphate 
sulphate 
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D=0.063 by haired t test 
Fig. 30 The effect of morphine sulphate 
on basal pressure in the 
cholecystectomy group 
p=0.026 by paired t test 
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PLATE J: THE RESPONSE OF THE PORCINE SPHINCTER TO 
MORPHINE SULPHATE 
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The effect on wave amplitude 
The sphincter of Oddi motility was also increased in both groups in 
response to Morphine sulphate. There was an increase in wave 
amplitude from 4mmHg (25th-75th centiles; 4-7mmHg) to 10mmHg (25th- 
75th centiles; 4-12mmHg) in the sham group (p=0.099 by paired t test) 
and from 4mmHg (25th-75th centiles; 0-4mmHg) to 7mmHg (25th-75th 
centiles; 4-12mmHg) in the cholecystectomy group (p=0.11 by paired t 
test)(fig. 31). The change in wave amplitude after morphine sulphate 
was not significantly different between the two groups (sham pre-post 
amplitude v cholecystectomy pre-post amplitude p=0.93 by Mann 
Whitney U test). 
Fig. 31 The effect of morphine sulphate on wave 
amplitude 
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p=0.60 by Mann 
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The effect on wave frequency 
Wave frequency increased from 1 cylce/minute to 3 cylces/minute in the 
both groups (fig. 32). There were no significant differences in response 
between the two groups ( sham pre-post wave frequency v 
cholecystectomy pre-post wave frequency p=0.51 by Mann Whitney U 
test) 
Fig 32 The effect of morphine sulphate on 
wave frequency 
Sham v 
cholecystectomy 
p= 0.8 by Mann 
Whitney U test 
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5.6 Discussion 
The basal pressures of our sham group were similar to those reported 
by Sand et al 1997. Interestingly we have found that in the majority of 
animals (9/14 (64%)) the sphincter of Oddi exhibited regular phasic 
acitivty (1/cycle/minute) a feature previously unreported. Sand et al 
failed to show phasic activity, probably because their observations were 
of short duration (pull-through recordings). Cannulation of the ampulla 
does lead to trauma and spasm of the sphincter and in fact this is 
believed to be important in the development of post endoscopic 
retrograde cholangiopancreatography pancreatitis (Sherman et al 1994). 
By observing a fifteen minute baseline recording the sphincter was 
allowed to settle and recover from any spasm induced by cannulation 
and thus our recordings were probably more physiological. The human 
sphincter of Oddi exhibits regular phasic activity (2-6cycles/minute) and 
therefore another characteristic of the porcine sphincter of Oddi has 
been found that strengthens its validity as a suitable animal model of 
sphincter of Oddi function. 
In this study we have found as in previous human (Luman et al 1997) 
and prairie dog (Grace 1987) studies basal activity of the sphincter of 
Oddi is not significantly altered after cholecystectomy. Luman et at 
reported an abnormal response to cholecystokinin after cholecystectomy 
with a failure of suppression of phasic activity. In this study the 
sphincter of Oddi in the cholecystectomy group failed to relax in 
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response to pharmacological doses of cholecystokinin in contrast to the 
sham group where a significant fall in basal pressure was observed. 
The mechanism by which this has occurred is unexplained, but as was 
postulated ((Grace et al 1987, Thune et al 1998, Luman et al 1997) it 
is possible that during cholecystectomy the division of nerves 
connecting the gallbladder and sphincter of Oddi, results in altered 
responsiveness to cholecystokinin. An alternative explanation is that the 
sphincter of Oddi relaxes in response to large surges of bile flow. It is 
possible that the sudden increase in bile flow after gallbladder 
contraction, brought about by cholecystokinin in response to a meal, 
leads to common bile duct distension which directly relaxes the 
sphincter of Oddi via local reflexes. Bile flows continuously through the 
sphincter of Oddi following cholecystectomy and therefore sphincter of 
Oddi relaxation may not occur after cholecystokinin injection due to a 
lack of common bile duct distension. More interestingly two of the 
seven cholecystectomy animals exhibited a paradoxical rise in basal 
pressure in response to cholecystokinin as has been seen in some 
patients with sphincter of Oddi dysfunction (Hogan et al 1982, Rolny et 
al 1986). The paradoxical rise in basal pressure supports the theory 
that denervation of the sphincter of Oddi may be the cause of 
sphincter of Oddi dysfunction (Helm et al 1989, Saccone et al 1994, 
Simula et al 1997, Simula et al 1997) and loss of the described 
cholecysto-sphincter-of-Oddi reflex (Muller et al 1984, Webb et at 
1988). This finding also supports the theory that cholecystectomy is a 
causal factor of sphincter of Oddi dysfunction and that sphincter of 
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Oddi dysfunction does not necessarily predate cholecystectomy. 
However factors other than just cholecystectomy must be involved in 
the aetiology of sphincter of Oddi dysfunction because sphincter of 
Oddi dysfunction has been described in patients with an intact 
gallbladder (Catalano et al 1991, Choudhry et al 1992, Lahoti et al 
1997, Catalano et al 1998) and because not all humans develop 
sphincter of Oddi dysfunction post cholecystectomy (5-30% of those 
patients with post cholecystectomy pain syndrome ( Bar-Meir et al 
1984, Brandstatter et al 1991)). 
The finding of a paradoxical rise in basal pressure in response to 
cholecystokinin in two pig raises the possibility that these animals may 
represent sphincter of Oddi dysfunction in pigs. This raises the exciting 
possibility that the goal of defining an animal model of sphincter of 
Oddi dysfunction has been achieved, further studies are warranted to 
confirm this. 
To date the action of morphine sulphate on the porcine sphincter was 
not known. The findings reported is this study show that intravenous 
morphine sulphate produces rapid stimulation of the porcine sphincter, 
resulting in a rise in basal pressure, as it does in man (Coehlo et 
1986, Helm et al 1988), thus lending further support for porcine model 
of sphincter of Oddi function.. Helm et al showed that the effects of 
morphine on the sphincter of Oddi were not mediated by cholinergic 
nerves. In this study the response to morphine sulphate was not 
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altered by cholecystectomy, therefore opiate receptors and pathways are 
unaltered by the disruption of neural networks between the gallbladder, 
sphincter of Oddi and duodenum following cholecystectomy. 
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CHAPTER 6 
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THE IN VIVO EFFECT OF SUBSTANCE P ON THE SPHINCTER OF 
ODDI. 
6.1 Introduction 
Substance P is a 11-amino acid oligopeptide which was first recognised 
as a vasoactive agent by Von Euler and Gaddum in 1931. It is found 
throughout the body but particularly in the central nervous system and 
gut (Holzer et al 1982, Pernow et al 1983). Immunohistochemical 
studies have shown that almost all intestinal substance P is present in 
neurons, and only a minor portion is contained in endocrine cells of 
the mucosa (Bartho et al 1985). It is for this reason that substance P 
has been regarded as a neurotransmitter or neuromodulator (Pernow et 
al 1983, Bartho et al 1985). Substance -P has been shown by 
radioimmunoassay to be present, in the gallbladder and bile duct tissue 
of the dog and rabbit (Brodin et at 1981,, Heitz et at 1977). 
Immunohistochemical studies have located substance P in the neural 
networks of both the porcine and human sphincter of Oddi (Sand et al 
1993, Sand et al 1994). 
Substance P has been shown to stimulate gallbladder contraction in the 
dog (Lembeck et al 1972) and guinea-pig (Bjurstedt et al 1940). More 
recently substance P has been shown in vitro to lead to contraction of 
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the dog sphincter of Oddi by direct binding to substance P receptors 
(Guo et al 1989) and also to increase myoelectric activity in the 
opossum sphincter (Parodi et al 1988). While substance P can be 
found in the neural network of the human and porcine sphincter of 
Oddi it action is not known. 
6.2 Aim 
The aim of this study was to determine the effect of substance P on 
the porcine sphincter of Oddi. 
6.3 Methods 
Seven large white female pigs (Sus-scrofus domesticus) were studied. 
Eight weeks previously two pigs had undergone a sham laparotomy 
and five pigs had undergone cholecystectomy. Manometry was 
performed using a triple lumen perfused catheter via a duodenotomy 
incision. The animals had all completed steps 1 to 5 of the study 
protocol detailed in chapter 4. A 15 minute washout period was 
observed after the morphine sulphate injection and then 0.5 mg of 
Substance P was given intravenously through an ear vein and 
manometric measurements were recorded for 5 minutes. 
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6.4 Statistical analyses 
Sphincter basal pressure and phasic activity were compared for the 5 
minutes before and after substance P. The results are therefore paired 
and statistical analysis was performed using Students paired t test. 
6.5 Results 
The sphincter of Oddi was seen to contract in all cases and visible 
gastric emptying was observed (gastric contents was seen to enter the 
duodenum). The results are tabulated in figure 33. The mean basal 
pressure rose significantly (p=0.008 by paired t test) from 4.3mmHg 
(range 0-18mmHg) to 14.4 (range 5-33mmHg)(fig. 34). Phasic activity 
significantly increased, wave frequency from 1.1 cycles/minute (range 0- 
4cycles/minute) to 4.1 cycles/minute (0-9cycles/minute) (p=0.014 by 
paired t test)(fig. 35) and mean wave amplitude rose from 3.4mmHg 
(range 0-14mmHg) to 12.1 mmHg (range 0-25mmHg) (p=0.018 by paired 
t test)(fig. 36). The results table 0, graphical representation of the data 
points and a typical manometry recording; plate K are shown overleaf. 
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Fitt. 33 THE IN-VIVO EFFECT OF SUBSTANCE P ON THE PORCINE 
SPHINCTER OF ODDI 
Basal pressure Wave Amplitude Wave Frequency 
mmHg mmHg MmHg 
Before 4.3 1.1 3.4 
substance P (2.34) (0.63) (1.99) 
After 14.4 4.1 12.1 
Substance P (3.34) (1.16) (3.11) 
p value 
Before v After p= 0.008 p= 0.018 p= 0.014 
(paired t test) 
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Plate K: The response of the porcine sphincter of Oddi to 
substance P 
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Fig. 34 The in vivo effect of substance P on the porcine sphincter 
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Fig. 35 The in vivo effect of substance P on the porcine sphincter 
of Oddi wave freauencv 
10 
p=0.018 
4.1 t 
....... 
gKfter 
Substance P 
Substance P 
151 
Fig. 36 The in vivo effect of substance P on the porcine sphincter 
of Oddi wave amplitude 
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6.6 Discussion 
This study reports the first description of the action of substance P on 
the porcine sphincter of Oddi, where it has a dual effect, to raise 
sphincter pressure and to increase phasic activity. This is also the first 
study to investigate the action of substance P in vivo, in a category 2 
(resistor type sphincter) animal. 
Studies in rats have shown that substance P stimulates peristalsis via 
the NK1 receptor(Holzer et at -1985, Holzer-Petsche et at 1987, Lecci 
et al 1997). Studies in man have shown that substance P stimulates 
small intestinal motility (Lordal et al 1997, Holzer et al 1997), and it 
has also been found to invoke canine gallbladder contraction in vitro 
(Guo et, al 1989). It is therefore likely that the action of substance P 
on the sphincter of Oddi is part of the more widespread stimulation of 
gut motility, indeed Guo et al found enhanced gastric emptying 
occurring shortly after the injection of substance P. It is possible that 
substance P and the NK1 receptor have a role in coordinating small 
bowel, gallbladder and sphincter of Oddi motility. 
More recently there have been advances in the understanding of the 
function of substance P and the NKI receptor within the pancreas. 
Substance P appears to be involved in the development of acute 
pancreatitis (Bhatia et al 1998). Studies in NK1 receptor knock-out mice 
show that in these mice lacking the receptor have an attenuated 
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inflammatory pancreatic and intrapulmonary response to caerulein 
induced pancreatitis. 
There is also evidence that substance P receptors are pivotal in the 
transmission of pain from visceral sensory nerves to the spinal cord 
and central nervous system (Cao et al 1989, Cao et al 1998 and De 
Felipe et al 1998). Domschke et al 1988 and Giorgio et al 1993 have 
shown that substance P receptors may be involved in the inflammatory 
process of chronic pancreatitis. Buchler et al 1992 suggested that 
substance P receptors may be responsible for the long-lasting pain 
syndrome in chronic pancreatitis. 
In summary, neurotransmitter substance P and its receptor NK1 may 
have a number of functions within the pancreaticobiliary system; as a 
neurotransmitter involved in sphincter of Oddi motility; in the modulation 
of the inflammatory response of acute pancreatitis; and in inflammatory 
and pain pathways of chronic pancreatitis. 
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CHAPTER 7 
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THE DEVELOPMENT OF A NEW MULTI LUMEN CATHETER FOR 
SPHINCTER OF ODDI MANOMETRY 
7.1 Introduction 
In chapter one the two catheters for endoscopic sphincter of Oddi 
manometry namely, the Lehman perfused catheter and the solid state 
microtransducer were discussed. Since their development approximately 
20 years ago there has been no change or advances in their design 
despite concurrent advances in catheter technology. The 
microtransducer catheter only measures the mean sphincter of Oddi 
pressure. Whereas the Lehman catheter is capable of measuring the 
pressure profile in two opposite directions. In ours and others 
experience the manometric pressure measurements taken from the two 
channels of the Lehman catheter may differ, possibly indicating that the 
sphincter of Oddi pressure profile is asymmetric in these cases. 
Examples from our lab of a normotensive symmetrical sphincter (Plate 
L), an asymmetric normotensive sphincter (Plate M) and an asymmetric 
hypertensive sphincter (Plate N) pressure profiles are shown. Agreed 
criteria for the interpretation of such recordings have not been devised 
(Hogan et al 1997), it is not clear whether to report the mean from 
the two channels, the lowest or highest basal pressure. A single study 
(n=288) has attempted to define sphincter asymmetry using the Lehman 
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PLATE LA NORMOTENSIVE SYMMETRICAL SPHINCTER 
MANOMETRY USING THE LEHMAN CAHTETER 
157 
PLATE M: A NORMOTENSIVE ASYMMETRIC SPHINCTER 
MANOMETRY USING THE LEHAMN CATHETER 
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PLATE NA HYPERTENSIVE ASYMMETRIC SPHINCTER MANOMETRY 
USING THE LEHMAN CATHETER 
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catheter by measuring the pressures in one plane and then changing 
the orientation of the catheter by ninety degrees and repeating the 
station pull-through (Patel et al 1998). Patel et al found that there is 
sphincter asymmetry in 88% (253/288) and this was more marked in 
patients with hypertensive biliary or pancreatic sphincters. However it 
seems unlikely that this group managed to orientate the catheter truly 
in two perpendicular planes because cannulation of the sphincter of 
Oddi is not easy at the best of times using the Lehman catheter and 
the preformed curve at the catheter tip does not facilitate changes in 
catheter orientation. The other problem with this study is that the 
Lehman catheter measuring ports are two millimetres (see plate B) 
apart in distance, the results therefore were manipulated to compensate 
for this 
Catheters are manufactured by the extrusion of a larger diameter multi 
lumen tube down to the required diameter. There are a number of 
difficult steps in this technique and key specifications which must be 
adhered too, namely: 
1. The lumen of each channel must remain separate from the 
adjacent channel and be patent. 
2. The distal measuring port hole must remain separate and, -not 
coalesce with adjacent holes, cutting of these holes is the most 
difficult step. 
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3. The walls of each channel must be non compliant so that the 
pressures in each channel is not transmitted across to adjacent 
channels. 
4. The catheter material must be rigid enough to allow guidance of 
the catheter through the endoscope channel and into the 
sphincter. 
Catheter diameter has been one of the key limiting factor in developing 
a catheter with more than three lumens because increasing the 
catheter diameter adversely affects the pressure measurements (Funch- 
Jensen et al 1984). Large diameter catheters also are more difficult to, 
pass down the endoscope, cannulate the biliary or pancreatic ducts 
with and are more likely to obstruct duct outflow, theoretically 
increasing the likelihood of pancreatitis . 
In order to measure asymmetry a catheter needs as many lumens as 
possible, and the measuring ports to open uniformly around the 360 
degrees of the catheter at a single level. The Lehman catheter clearly 
fails to achieve this objective. However catheters have been developed 
for the assessment of the lower oesophageal sphincter and anal 
sphincter asymmetry using a method termed as vector manometry 
(Williams et al 1994, Zbar 1999, Bombeck et al 1987, Stein et al 
1991, Sluss et al 1995, Stein et al 1995). Vector manometry by 
definition defines a three dimensional contour map of sphincter function. 
In the assessment of these sphincters it is commonly performed using 
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a perfused muilti-lumen catheter which is pulled through the sphincter 
at a fixed rate using a mechanical puller unit. Vector analysis computer 
programs are utilised to interpret the results and determine the radial 
pressure profile at the point of peak pressure from which three 
dimensional contour maps can be drawn. These computer programs are 
able to calculate the vector volume and also the radial asymmetry. The 
latter is calculated according to this formula: 
Radial asymmetry =1-(P, + P+ P3+ P4--- P. 
) 
x 100% 
nx maximum of P, {, 
n= the number of recording channels. 
A perfectly symmetrical sphincter has a radial asymmetry of 0%. 
Within the anal canal this technique has been used to assess obstetric 
sphincter damage (Donnelly et al 1998, Donnelly et at 1998). Sluss et 
al reported that patients with low pressure lower oesophageal 
sphincters were more likely to have asymmetric sphincters and it was 
speculated that in some patients with low pressure sphincter the 
degree of asymmetry in the sphincter could be an important factor in 
reflux events. At present a suitable catheter for sphincter . of Oddi vector 
manometry is not available and therefore vector manometry of the 
human sphincter of Oddi has not been performed. 
In conjunction with Medi-plus, U. K a company which has previously 
specialized in the manufacture of uro-dynamic catheters, we have 
developed a new 9 lumen manometry catheter as shown in Plate 0. 
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This catheter of seven French diameter made of an ultra-low compliant 
PVC, has one central lumen which opens at the tip of the catheter 
and eight recording channels which terminate in side openings 
equidistantly spaced and radially arranged in 45° intervals 5mm for the 
distal end of the catheter. 
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Plate 0: The new nine lumen biliarv manometry catheter 
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7.2 Aims 
1. To bench test the new nine lumen catheter to determine the 
catheter's fidelity. 
2. Using a porcine animal model to assess if the new nine lumen 
catheter recordings are reproducible. 
3. Using a porcine animal model to assess agreement of the new 
nine lumen manometry pressure recordings with the Lehman 
triple lumen catheter. 
4. To assess the feasibility of assessing human sphincter of Oddi 
asymmetry using the new nine lumen catheter. 
7.3 Methods 
7.3.1 ' Bench test of the new nine lumen catheter. 
As discussed in chapter 3, ideally all manometric systems should be 
capable of recording absolute values of the pressure wave with 
accuracy . Both pressure rise rates and baseline offset are indicators 
of catheter fidelity (Omari et al 1996, Chen et al 1998)'}326M}. Pressure 
rise rate was determine for the new, nine lumen catheter with perfusion 
pressures of 0.1,0.2 and 0.3 bar by occlusion of the measuring hole 
and determining the mean pressure rise per second. The baseline 
offset was determined for the same perfusion pressures by calibrating 
and zeroing to air the perfusion system and then connecting the 
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primed catheter and the pressure recorded as the, baseline offset. Flow 
rates were determine by collecting the perfusate over a five minute 
period for each perfusion pressure and calibration studies were 
performed using the same sealed system described in chapter 3. 
7.3.2 The assessment of the new nine lumen catheter using a porcine 
animal model 
Seven female 20-25kg pigs were studied according to the protocol 
below. 
1. Each animal was anaesthetised with a combination of enflurane, 
nitrous oxide and oxygen by inhalation and midazolam as an 
intravenous infusion. 
2. Endoscopic sphincter of Oddi manometry was performed using the 
new nine lumen catheter, (only 6 of the 8 measuring channels were 
used due to limitations of the computer software available at the 
time). The catheter was introduced into the sphincter and positioned 
so that the measuring ports were located 1 cm within the duct. A 
station pull through was then performed using five stations, 2mm 
apart. Two pull-throughs were performed in each case. 
3. A single station pull-through manometry was then performed using 
the Lehman catheter from Urn within the duct with five 2mm apart 
stations. 
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4. The results of each pull-through with the new nine lumen catheter 
were compared to assess reproducibility. 
5. Results were analyzed to compare the mean pressure recordings of 
the new nine lumen catheter with the mean pressure from the 
Lehman catheter for the distal 1 cm of the bile duct where the 
sphincter of Oddi is sited. 
7.3.3 The feasibility of assessing human sphincter of Oddi pressure 
asymmetry using the new nine lumen catheter 
Six patients with suspected sphincter of Oddi dysfunction, determined 
on clinical grounds, were studied according to this standard protocol: 
1. Patients were sedated with diazemuls (10-30mg) and pethidine 
(50-100mg). 
2. Video duodenoscopy was performed using a diagnostic 
duodenoscope (Olympus, U. K). 
3. The new nine lumen catheter was perfused with bubble free 
water at a pressure of 0.2 bar from an Arndorfer 
pneumohydraulic pump at a rate of 0.16m1/channel/minute. 
4. Endoscopic manometry was performed using the new nine lumen 
catheter by a station pull-through technique with 0.5cm apart 
stations. 
5. The central lumen was continually aspirated to decompress the 
duct and reduce the incidence of procedure related pancreatitis. 
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6. The data was captured and analysed using a computer based 
manometry program (Albyn Medical, U. K. ). 
Two-dimensional radial pressure profiles were drawn from the mean 
basal pressure in each channel at each station. The radial profiles 
were then combined from the distal common bile duct through to distal 
sphincter orifice to form a three-dimensional pressure profile. As yet a 
suitable pull apparatus has not been developed and therefore manual 
pull-throughs were performed it is therefore not possible to accurately 
determine the vector volume from this data and the assessment of 
radial asymmetry is also limited. However from this data the radial 
asymmetry was at each station was estimated using the formula 
described above and then the mean radial asymmetry was calculated 
for each patient. The mean radial asymmetry was compared with the 
visual appearance of the 2 dimensional and 3 dimensional pressure 
profiles. 
7.4 Statistical methods 
Linear regression analysis was used to determine the correlation 
coefficient to assess agreement of two pull-throughs with the new multi- 
lumen catheter. To compare the new catheter with the Lehman catheter 
the plot of the difference against the average of the standard and new 
method was determined as described by Martin et al 1995. 
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7.5 Results 
7.5.1 Bench testing of the new nine lumen catheter 
The pressure rise rate increased with perfusion pressure with a mean 
pressure rise rate of 51 mmHg/sec at a perfusion pressure of 0.2 bar. 
The pressure rise rate against time is illustrated below (fig. 37). 
Fig. 37 Pressure rise rate for 
the new nine lumen catheter 
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The baseline offset also rose with increased perfusion pressure 
although the baseline offset at 0.2 was the same as at 0.1 bar, 
36mmHg. The graph below (fig. 38) illustrates the baseline offset 
against perfusion pressure. 
Fig 38 Baseline offset for 
different perfusion pressures 
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The flow rate also increased with perfusion pressure (fig. 39). The 
recorded catheter pressures appeared to correlate well with the actual 
pressures at all perfusion pressures (figures 40,41 and 42). The flow 
rates and calibration graphs are shown overleaf. 
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Fig. 39 Flow rates for different 
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Fig. 40 Calibration of the new nine 
lumen catheter perfused at 0.1 bar 
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Fig. 42 Calibration graph for the 
new nine lumen catheter 
perfused at 0.3 bar 
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7.5.2 The assessment of the new nine lumen catheter using a porcine 
animal model 
Cannulation of the bile duct was achieved in all six animals in which 
the biliary ampulla was located. One study was excluded from analysis 
because in this animal the ampulla was not located due to a deformed 
duodenum and therefore cannulation was not achieved. The results are 
displayed below (fig. 43). 
The two pull-throughs performed with the new multi-lumen catheter 
showed significant correlation (r=0.92, p=0.0025), the linear plot is 
shown below (fig. 44). 
The comparison of the mean manometric pressures of the Lehman and 
the new nine lumen catheters showed poor correlation when comparing 
the average difference against the average measurement of the two 
methods (r=0.53, p=0.09), as shown below (fig. 44). 
174 
Fig. 43 The results of porcine sphincter of Oddi manometry using the 
new nine lumen catheter and the Lehman catheter 
Mean basal pressure (mmHg) 
The new 9 lumen catheter Lehman 
PIG No. Pull-through 1 Pull through 2 Catheter 
304 7.0 7.0 11.5 
305 1.0 4.5 11.2 
306 17.0 16.0 9.0 
307 7.0 9.0 13.5 
308 9.3 8.0 10.6 
309 13.8 12.0 13.3 
175 
Fig. 44 The assessment of the new nine lumen catheter in a porcine 
animal model 
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7.5.3 The feasibility of assessing human sphincter of Oddi pressure 
asymmetry using the new nine lumen catheter 
It was possible to cannulate the bile duct and perform a satisfactory 
biliary sphincter pull-through in all patients with the new nine lumen 
catheter. No procedure related episodes of pancreatitis occurred. 
A standard eight lumen recording is shown in plate P, phasic activity 
and a rise in basal pressure denoted the position of the sphincter of 
Oddi. Examples of the two-dimensional plot and three dimensional 
sphincter profiles are shown in plates Q, R and S. The radial 
asymmetry varied tremendously from 21% to 66% as shown in the 
table below (fig. 45). 
Fig 45 The mean basal pressure and calculated radial asymmetry 
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PLATE P: A TYPICAL 8 CHANNEL RECORDING USING THE 9 
LUMEN CATHETER 
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PLATE Q: 2D and 3D pressure profile diagrams 
Radial asymmetry 27% 
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Plate R: 2D and 3D pressure profile diagrams 
Radial asymmetry=32% 
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Plate S: 2D and 3D pressure profile diagrams 
Radial asymmetry = 21 % 
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7.6 Discussion 
The bench studies for the new nine lumen catheter show that its 
fidelity compares favourably with the Lehman catheter reported in 
chapter 3. The pressure rise rate for the new nine lumen catheter was 
higher than the Lehman catheter for a given perfusion pressure and 
the back pressure was lower for a given pressure. The catheter 
recorded set pressures accurately. The total flow rate was higher for 
the new nine lumen catheter due to the greater number of lumens 
(1.3mis/minute for the new nine lumen catheter compared with 
0.38mis/minute for the Lehman catheter at a perfusion pressure of 
0.2bar). Potentially this may increase the risk of procedure related 
pancreatitis because the incidence of procedure related pancreatitis 
increases with increases in catheter flow rate (Meshkinpour et al 
1992). '}"'`}, however in this albeit small group there were no episodes 
of pancreatitis. 
Results from the porcine study show that measurements made by the 
nine lumen catheter are reproducible (r=0.92, p=0.0025). However 
results from the new nine lumen catheter when compared with the 
pull-through by the Lehman catheter did not agree. The statistical 
method used in this study is superior than by simple correlation 
analysis and is the recommended statistical method for comparing 
methods of measurement (Martin et al 1995). However, Martin et al 
realise that it is unlikely that any method will agree exactly and with 
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small sample groups, small differences in measurements will have 
significant impact on the statistical analysis. This study of six animals 
(due to constraints from the Home Office) is regarded as small, and 
this has an impact on the conclusions drawn. A larger study comparing 
the recordings of the two catheters in normal human volunteers would 
be the ideal however ethical constraints due to the risk of 
complications are unlikely to make this possible. 
In contrast to the Lehman catheter the new nine lumen catheter 
provides a complete 360 degree pressure profile of the sphincter of 
Oddi. Firstly it was possible to locate the catheter within the bile duct 
in all subject, this is a 'significant accomplishment because sphincter of 
Oddi manometry is regarded as one of the most difficult techniques to 
master for any experienced endoscopist. The measurements made by 
the nine lumen catheter indicate that the human sphincter of Oddi is 
asymmetric. Therefore measurements using the Lehman catheter are 
seriously flawed due to the limited sampling from two channels. 
The high pressure zone was consistently shown to be directed upwards 
towards the transverse fold. This is to be expected because the 
anatomy of the sphincteric muscle is of a figure of eight around the 
pancreatic and biliary ducts and therefore the thickest muscle layer can 
be expected to be located between the two sphincters i. e. in an 
upward direction when assessing the biliary sphincter. This method of 
assessing sphincter of Oddi symmetry may improve the efficacy of 
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endoscopic sphincterotomy, which although proven in Milwaukee type 2 
patients, is unproven in type 3 patients with hypertensive sphincters 
(Bozkurt 1996, Wehrmann 1996). It may be possible to direct the 
sphincterotomy towards the defined high pressure zone of the sphincter 
for example, in plate R the sphincterotomy should be directed towards 
11-12 o'clock, which is away from the orthodox 12-1 o' clock biliary 
sphincterotomy direction. (Danilewitz, et at 1984, Neoptolomos et at 1984, 
Neoptolomos et al 1988, Wehrmann et al 1996, Cotton et al 1998) ). 
Studies are required to evaluate the manometric and symptomatic 
efficacy of a manometrically directed sphincterotomy. 
This study was a feasibility study to assess whether it was possible to 
record sphincter of Oddi pressures endoscopically using the new nine 
lumen catheter we have therefore achieved what we set out to do. 
However as indicated it was not possible to perform vector volume 
analysis and the radial asymmetry calculations are of limited value 
using the apparatus employed, predominantly due to the lack of 
mechanical pulling device and the limitations of the computer recording 
and display package. Further work is required to develop an apparatus 
in which the endoscope could be fixed once the catheter is located 
within the duct after which evaluation of a mechanical pulling device 
could be performed. The essential feature of the mechanical pulling 
device is that it must be able to withdraw the catheter through the 
sphincter at a constant and set rate. To achieve this the pulling device 
must be able to overcome the resistance of the catheter within the 
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biopsy channel of the endoscope and the rate of pull must be fast 
enough to minimise the effect of respiratory movement. Potentially, 
mechanical pulling devices used for oesophageal and ano-rectal studies 
could be used. There are already computer programs (Synectics Ltd, 
U. K. ) available to assess the oesophageal and anal sphincter and 
these could also be easily adapted to measure the sphincter of Odd!. 
It is theoretically possible, now that this new nine lumen catheter has 
been developed, to perform true vector manometry of the sphincter of 
Oddi 
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Chapter 8 
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AN AUDIT OF SPHINCTER OF ODDI MANOMETRY PERFORMED AT 
THE ROYAL LONDON HOSPITAL. 
8.1 Introduction 
Sphincter of Oddi manometry is common practice in the U. S. A, 
Australia and Japan, but within Britain there are only a few centres 
carrying it out and none have published audit data of their outcomes. 
The clinical service at the Royal London Hospital was established in 
1993 by Dr Colin Ainley ( the endoscopist) and Dr David Evans (the 
physiologist). I have subsequently joined this team and carry out the 
endoscopic procedure as well as data interpretation and reporting. The 
London Hospital receives many tertiary referrals from the North East 
Thames region and it is from this patient group that the referrals for 
sphincter of Oddi manometry arise. Most referrals are from consultant 
Gastroenterologists and a few from consultant Surgeons. 
8.2 Aim 
The aim of this study was to audit the outcome of 52 patients 
following who underwent sphincter of Oddi manometry between August 
1993 and August 1996 at the Royal London Hospital. 
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8.3 Methods 
All manometries were performed by a single endoscopist Dr. C. Ainley. 
Sphincter of Oddi manometry was performed by a standard technique: 
1. Patients were sedated with diazemuls (10-30mg) and pethidine 
(50- 100mg). 
2. Endoscopic manometry was carried out by a station pull-through 
technique using two of the three channels of the Lehman (Wilson- 
Cook, USA) catheter. The catheter was perfused with bubble free 
water from a low compliance Arndorfer pneumohydraulic pump at a 
rate of 0.2m1/minute/lumen. 
3. The third central lumen of the Lehman (Wilson-Cook, USA) catheter 
was continually aspirated to reduce the incidence of pancreatitis 
(Sherman et al 1990)1)11794). -- -' 
4. A second single lumen catheter was attached to the outside of the 
duodenoscope to record duodenal pressure. This catheter was 
perfused and transduced as above. 
5. Attempts were made to achieve manometric measurements of both 
the pancreatic and biliary sphincters in all cases. 
6. Manometry data was captured and analysed using a computer 
based manometry system. (Albyn Medical, U. K. ). 
Audit data was collected by obtaining the manometric records and the 
medical records of the patients. These were systematically reviewed by 
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Dr. A. Millar and Dr. E. A. Stoner. Patients were classified according to 
results of manometry; namely a hypertensive sphincter of Oddi (basal 
pressure >40mmHg) with or without tachyoddia (phasic activity >8 
cycles per minute), tachyoddia alone , or normal. 
8.4 Results 
Sufficient follow up data was available for 37 of the 52 patients and is 
represented below (fig. 46). 
Fig. 46 The results of the audit of sphincter of Oddi manometry 
performed at the Royal London Hospital from August 1993 to August 
1996 
Median age (range) 36 (25-79) 43 (32-37) 43 
(19-42) 
Sex (F: M) 11: 02 03: 00 15: 06 
Post-cholecystectomy (%) 5 (38) 0 (0) 2 (10) 
RUQ pain (%) 5 (38) 3 (100) 17 (80) 
Pancreatitis (%) 3 (23) 0 (0) 2 (10) 
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Number 13 3 21 
Most of the -patients investigated were female (78%) and most of the 
patients (25(67%)) were classified into Milwaukee biliary type 3. No 
episodes of procedure related pancreatitis occurred. 
Twenty-one (57%) of the thirty-seven had normal basal sphincter of 
Oddi pressure.. Thirteen patients (35%) had a hypertensive sphincter of 
Oddi basal pressure with or without associated tachyoddia. Three 
patients (8%) were found to have tachyoddia alone. Of the thirteen 
patients with a hypertensive sphincter of Oddi, ten had undergone 
endoscopic sphincterotomy at the time of this review. Symptom 
resolution was achieved in seven (70%) (follow-up 3- 20 months). 
Of the twenty-one-with normal sphincter of Oddi manometry, eleven 
(52%) have subsequently been given alternative diagnosis and symptom 
resolution has occurred spontaneously in two of the remaining ten. 
8.5 Discussion 
Satisfactory patient follow-up was achieved in only 71 % of patient. 
Contact was carried out by writing or telephoning the referring 
consultants secretary and depended on good will to forward the 
appropriate information. Information gathering and data collection could 
have been improved upon, by visiting the appropriate hospitals and 
seeking appropriate authorization to view patient records. 
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Since the introduction of this clinical service there has been a steady 
referral rate of patients with symptoms suggestive of sphincter of Oddi 
dysfunction. According to the Milwaukee classification our patients are 
predominately type 3 and a few type 2. By definition type 3 patients 
have only biliary type pain and as in other studies relatively few 
patients were found to have a hypertensive sphincter of Oddi (Hogan 
et al 1987, Wehrmann et al 1996, Hogan et al 1997). This mixture of 
type 2 and 3 patients explains why symptomatic relief was achieved in 
only 70% following sphincterotomy (Wehrmann et al 1996). The low 
rate of referral of patients categorised as Milwaukee type 1 patients 
was expected because in these patients after diagnostic endoscopic 
retrograde cholangiopancreatography they often go on to therapeutic 
sphincterotomy as a therapeutic trial rather than being referred for 
manometry. This course of management for type 1 patients is 
acceptable under current recommendations (Lans et al 1991, Hogan et 
al 1997). It is possible that type 2 patients have likewise undergone 
sphincterotomy as a therapeutic trial because referral for sphincter of 
Oddi manometry is regarded by many clinicians as a "last resort" 
investigation in patients with posing a diagnostic dilemma. 
Of the patients found to have normal sphincter pressures half have 
been given alternative diagnosis, mainly irritable bowel syndrome or 
gastro-oesophageal reflux. Exclusion of sphincter of Oddi dysfunction 
was probably useful in the future management of these patients. 
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Surprisingly there were no episodes of pancreatitis which may be due 
to the aspirating technique employed and the low water perfusion rate 
used. (Sherman et al 1990, Meshkinpour et at 1992). " The aspirating 
technique has also been proved to be useful in collecting pancreatic 
juice for other studies. 
At this time dynamic studies were not part of our standard protocol. It 
is now our current practice to perform dynamic studies with both 
cholecystokinin (Kinevac, Bracco Diagnostics, USA) (20ng/kg bolus) and 
secretin (GIH, Kabi Diagnositca, Sweden) (1CU/kg bolus) with the 
catheter located midway in the high pressure zone. 
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CHAPTER 9 
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TACHYODDIA INDEPENDENT OF THE DUODENAL MIGRATING 
MOTOR COMPLEX MAY BE A PART OF SPHINCTER OF ODDI 
DYSFUNCTION. 
9.1 Introduction 
During fasting in most mammals, the gastrointestinal tract exhibits 
cyclical changes in activity called the migrating motor complex. The 
migrating motor complex consists of four phases, phase 1a period of 
quiescence; phase 2 shows irregular intermittent contractions; phase 3 
is characterized by periods of short bursts or regular high-amplitude 
contractions; and phase 4 is a brief transition back to another 
quiescence (Sarna et al 1985). The phasic activity of the sphincter of 
Oddi of opossums (Honda et al 1982, Tanaka et al 1990) and dogs 
(Scott et al 1984, Scott et al 1984, Yokahata et al 1994) have been 
shown to vary with the phasic activity of the duodenum, with maximal 
activity at the time of phase 3 of the migrating motor complex. In man 
the phasic activity sphincter of Oddi phasic activity varies in synchrony 
with the migrating motor complex (Torsoli et al 1986). Tanaka et al 
1992 reported a study of ten post cholecystectomy patients, using a 
solid state catheter with two mircotransducers one to measure sphincter 
of Oddi pressure and one to measure duodenal activity. There was a 
transient elevation in basal sphincter of Oddi pressure in concert with 
phase 3 of the migrating motor complex and it was suggested that this 
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could contribute to the development of intermittent post cholecystectomy 
pain in some patients. However Tanaka's study did not have a control 
group and therefore a rise in basal pressure during the fast phase of 
the migrating motor complex may be a normal finding. The normal 
frequency for sphincter of Oddi phasic activity is 2-6 cycles per minute 
and above 8 cycles per minute is considered abnormal (Toouli et al 
1990). The term tachyoddia has been applied to this state of 
abnormally high frequency activity (Toouli et al 1990, Hogan et al 
1995). At present the pathological significance of tachyoddia is not 
known and its presence is not a recognised indication for endoscopic 
sphincterotomy (Geenen et al 1989, - Lans et al 1991, Hogan et al 
1995). 
9.2 Aims 
The aims of this study were to: 
1. To determine the incidence of tachyoddia in our series of 65 
consecutive sphincter of Oddi manometries. 
2. To determine if tachyoddia is always synchronous with or may be 
independent to the fast phase 3 of the duodenal migrating motor 
complex. 
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9.3 Methods. 
The sixty-five consecutive sphincter of Oddi manometries were 
retrospectively reviewed by Dr E. A. Stoner. All manometries were 
performed in a standard way and duodenal activity was simultaneously 
recorded using a perfused catheter attached to the outside of the 
duodenoscope (as described in chapter 8). Phasic activity of the 
sphincter of Oddi greater than eight cycles per minute was defined as 
tachyoddia. The recordings were analysed to determine the incidence of 
tachyoddia in our sample. If tachyoddia occurred at a time when there 
was marked duodenal activity then this was termed as synchronous 
tachyoddia. If tachyoddia occurred when there was no or little duodenal 
phasic activity, phase one of the migrating motor complex, the 
tachyoddia was defined as being independent. 
9.4 Statistical methods 
The Fishers exact test was used to whether tachyoddia was associated 
with from the migrating motor complex. 
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9.5 Results 
Fifteen (23%) of the sixty-five recordings had at least one episode of 
tachyoddia. Ten (67%) of the episodes of tachyoddia were synchronous 
with the duodenal phasic activity and five (23%) were independent. Of 
the five that were independent most (4/5) were associated with a 
raised basal pressure and conversely tachyoddia (9/10) synchronous 
with the migrating motor complex was more commonly associated with 
a normal pressure. The results are tabulated below (fig. 47). 
A raised basal pressure was significantly (Fisher's exact test; two 
sided; p=0.0007) associated with tachyoddia independent from the 
duodenal migrating motor complex. 
Examples of typical recordings with tachyoddia independent to and 
synchronous with the migrating motor complex are shown in plate T 
and U respectively. 
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Fig. 47 The relationship of tachyoddia to the duodenal migrating 
motor complex 
Tachyoddia Tachyoddia 
synchronous independent 
Basal Pressure with the from the Total 
migrating motor migrating motor 
complex complex 
Raised 1 4 5 
(>40mmHg) 
Normal 9 1 10 
(<40mmHg) 
Total 10 5 15 
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PLATE T: TACHYODDIA INDEPENDENT TO THE DUODENAL 
MIGRATING MOTOR COMPLEX. 
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Plate U: Tachvoddia synchronous with the duodenal migrating 
motor complex 
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9.6 Discussion 
This study is the first to show that sphincter of Oddi phasic activity 
may be independent to the duodenal migrating motor complex. This 
observation suggests that the sphincter of Oddi has its own intrinsic 
pacemaker activity. It is probable that the neural connections between 
the gallbladder, duodenum and sphincter of Oddi co-ordinate phasic 
acitivty, similar to the sino-atrial node, atrio-ventricular node and 
purkinje fibres of the heart, (Dahistrand et al 1995, Padbury 1993, 
Simula et al 1997, Simula et al 1997). Disruption of these pathways at 
cholecystectomy could lead to independence of the sphincter of Oddi 
from the duodenal activity as occurs in the ventricles of the heart in 
complete heart block. 
It is important to note that independent tachyoddia occurred more 
commonly in patients with hypertensive sphincters. Therefore 
independent tachyoddia may be a part of sphincter of Oddi dysfunction. 
The term biliary colic by definition is a fluctuant pain, and may be due 
to the fast high pressure phasic activity of a sphincter which is not 
only hypertensive but exhibits tachyoddia. 
Nausea and bilious vomiting are common symptoms of 
postcholecystectomy syndrome (Drossman et al 1993, National Institutes 
of Health Consensus Conference on Laparoscopic Cholecystectomy 
(1993)) and may be due to altered antroduodenal activity following 
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cholecystectomy, reducing the duration of phase 3 of the migrating 
motor complex as compared to normals (Perdikis et al 1994). Perdikis 
et al 1994 found gastric pH>3 for a significantly longer time in the 
symptomatic post cholecystectomy group compared to asymptomatic 
patients. In this study duodenogastric reflux was also assessed using a 
gastric aspiration technique following an infusion of 99mTc-DISIDA. 
Significantly higher radioactivity of the aspirates was found in the 
symptomatic patients compared to normals (P<0.001) and asymptomatic 
controls (P<0.01). It has been suggested that removal of the 
gallbladder leads to loss of the bile reservoir and the disordered 
antroduodenal activity leads to duodenogastric reflux. From our findings 
it is also possible that the disordered sphincter of Oddi activity leads to 
pooling of bile in the duodenum and therefore promoting duodenogastric 
reflux. 
The method of station pull through manometry only provides a 
snapshot of the sphincter activity and to further define the activity of 
the sphincter of Oddi more prolonged studies of the sphincter and 
duodenal pressures are required. 
Morphine sulphate is known to induce phase 3 of the migrating motor 
complex and studies have shown a synchronous rise in basal sphincter 
of Oddi pressure in dogs (Yokohata 1994) and pigs (Stoner 1998) and 
in man (Ogawa 1992). It is possible that morphine sulphate could be 
used in a provocation study, devised to invoke phase 3 of the 
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migrating motor complex and phasic activity of sphincter of Oddi 
manometry and assess their relationship. 
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Chapter 10 
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CONCLUSION 
10.1 Summary and discussion of work presented 
The development of laparoscopic cholecystectomy has led to a 
significant rise in the annual number of cholecystectomies performed 
due to a lower threshold for surgery (Lam et al 1996). As a 
consequence, the prevalence of post-cholecystectomy pain syndrome is 
increasing, despite the more favourable outcome that laparoscopic 
surgery provides, 77-95% report satisfactory symptom relief (Peters et 
al 1996, Velpen et al 1993, McMahon et al 1995, Luman et al 1996)). 
Sphincter of Oddi dysfunction is believed to be one of a number of 
putative causes of post cholecystectomy pain (5-30% of patients with 
post-cholecystectomy pain syndrome (Bar-Meir et at 1984, Brandstatter 
et al 1991)). Although less invasive techniques have been used to 
diagnose sphincter of Oddi dysfunction, sphincter of Oddi manometry is 
regarded as the gold standard. The results of sphincter of Oddi 
manometry are proven to be predictive of the outcome of therapeutic 
sphincterotomy (Geenen et al 1990, Kaikaus et al 1995). 
In view of the risk of pancreatitis (up-to 25% Albert et at 1988, 
Sherman et al 1992, Rolny et al 1992, Catalano et al 1998) it is no 
longer acceptable to perform manometry on normal individuals or 
experiment on symptomatic individuals. Therefore suitable animal models 
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are important for the development of new techniques. The majority of 
studies to date have developed small animal models such as the 
opossum or cat and in these animals manometric measurements 
cannot be made with the same apparatus as in man and so are not 
ideal. Although the dog is suitably large to study endoscopically, its 
use is more strictly controlled by the Home Office and incurs 
considerable expense. In this thesis a porcine animal model has been 
developed. - The advantages of the pig over other animal models are; 
the pig is large enough to enable endoscopic manometry to be 
performed, the porcine sphincter of Oddi responds similarly to man to 
cholecystokinin, and pigs are relatively cheap to purchase and keep 
(Pasricha et al 1995). 
Animal studies often require the use of general anaesthesia not only to 
meet approval from the Home Office by ensuring no suffering is 
incurred but also to keep the animal still and provide a safe 
environment in which to perform endoscopic techniques. It is essential 
that the anaesthetic agents used do not influence sphincter of Oddi 
motility. In chapter four a combination of enflurane, nitrous oxide and 
oxygen by inhalation and midazolam by intravenous injection was found 
to be a suitable anaesthetic regime (Stoner et al 1998). Conversely 
halothane was found to suppress porcine sphincter of Oddi motility and 
should be avoided (Stoner et al 1998). 
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In chapter 5 attempts have been made to explore the aetiology of 
sphincter of Oddi dysfunction and to develop the porcine model with a 
view to developing an animal model of sphincter of Oddi dysfunction. 
Cholecystectomy when compared to sham laparotomy did not appear to 
alter resting basal pressure or-phasic activity, however it did dampen 
the inhibitory response to pharmacological doses of cholecystokinin but 
the stimulatory effect morphine sulphate was unaltered. This finding 
supports the theory that cholecystectomy is a causal factor of sphincter 
of Oddi dysfunction and that sphincter of Oddi dysfunction does not 
necessarily, predate cholecystectomy. However factors other than just 
cholecystectomy must be involved in the aetiology of sphincter of Oddi 
dysfunction because sphincter of Oddi dysfunction has been described 
in patients with an intact gallbladder (Catalano et al 1991, Choudhry et 
al 1992, Lahoti et al 1997, Catalano et al 1998) and because not all 
humans develop sphincter of Oddi dysfunction post cholecystectomy (5- 
30% of those patients with post cholecystectomy pain syndrome ( Bar- 
Meir et al 1984, Brandstatter et al 1991)). 
Two post-cholecystectomy animals exhibited an abnormal, paradoxical 
(rise in basal pressure) response to cholecystokinin. In man a 
paradoxical rise in sphincter of Oddi basal pressure is regarded as a 
diagnostic' feature of sphincter of Oddi dysfunction and is seen more 
commonly in patients with associated irritable bowel syndrome (Hogan 
et al 1982, Rolny et al 1986). It is possible that this sub-group of 
post-cholecystectomy animals are representative of porcine sphincter of 
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Oddi dysfunction. This statement is limited by the small numbers 
studied in this project in order to conform to the restrictions set by the 
Home Office and larger confirmatory studies are now warranted. This 
study is the first to report phasic activity of activity of the porcine 
sphincter of Oddi (Icycle/minute) probably due to the prolonged 
recordings observed in these studies. Morphine sulphate was found to 
stimulate the porcine sphincter of Oddi manometry with an increase in 
basal pressure and phasic activity. Therefore morphine sulphate may be 
a suitable agent to use when stimulation of the porcine sphincter is 
required. The characteristics of the porcine sphincter closely resemble 
the human sphincter and is, a suitable model for the investigation of 
the sphincter of Oddi function, alleviating the risk of causing 
pancreatitis in human subjects. 
Substance P is an important neuropeptide found in the visceral sensory 
nerves, the central nervous system and the enteric nervous system 
(Anonymous 1993, Costa et al 1982) Via the latter pathway it is 
believed to modulate peristalsis (Anonymous 1993, Costa et al 1982). 
Immunohistochemical studies have shown this oligopeptide to be 
present in both neural networks of the human and porcine sphincter of 
Oddi (Sand 1993,1994) however its action was not known. In chapter 
6 it was found that intravenous exogenous substance P leads to 
stimulation of the porcine biliary sphincter. This is the first description 
of the action of substance P on not only the porcine sphincter but on 
any animal with a type 2 (resistor like) sphincter of Oddi. It is possible 
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that substance P and the NK1 receptor may have a role in 
coordinating small bowel, gallbladder and sphincter of Oddi motility. 
Others have found that substance P may play a pivotal role in the 
development of acute pancreatitis and also in the pain pathway of 
chronic pancreatitis (Cao et al 1989, Cao et al 1998 and De Felipe et 
al 1998, Domschke et al 1988 Giorgio et al 1993, Buchler et al 1992). 
Future work should assess the action of substance P on the porcine 
pancreatic sphincter and the action of substance P receptor antagonist 
on both sphincters. 
Sphincter of Oddi manometry has been performed endoscopically using 
two types of catheters, the Lehman (Wilson -Cook) triple lumen 
perfused catheter and the solid state catheter favoured by Eastern 
countries. To date one unsatisfactory study has assessed symmetry of 
the sphincter of Oddi (Patel et al 1998). In chapter seven a new nine 
lumen catheter has been developed and used in man. This catheter 
has eight recording channels which are evenly spaced around the 
circumference of the catheter terminate at one level. Bench studies 
have shown that this catheter's fidelity compares favourably with the 
Lehman catheter. The feasibility study in a group of patients with 
suspected sphincter of Oddi dysfunction was successful and it is now 
possible to obtain a 360 degree pressure profile of the human 
sphincter of Oddi for the first time. Interestingly the sphincter of Oddi 
was found to be asymmetric, this is a cause of concern when 
measuring sphincter pressures using the Lehman catheter due to its 
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limited bi-directional measurement.. The efficacy of therapeutic 
sphincterotomy may be improved with detailed mapping of the sphincter 
pressure profile, by enabling directed cuts towards the high pressure 
zone. There were no episodes of pancreatitis with this method though 
larger studies are required to confirm it to be a safe technique. Further 
developments are required in order to perform true vector manometry 
and vector volume analysis, but with this new catheter design it seems 
possible. 
The audit of the first fifty-two sphincter of Oddi manometries at the 
Royal London Hospital has given insight into the outcome of the 
largest series of cases in the United Kingdom. The relatively low 
incidence of hypertensive sphincters reflects the pre-selected group of 
patients investigated, those classified as Milwaukee type 2 or 3, 
because type 1 patients are likely to have undergone diagnostic/ 
therapeutic endoscopic sphincterotomy. The practice of simultaneously 
measuring duodenal activity at the time of sphincter of Oddi manometry 
has interestingly shown that tachyoddia independent to the duodenal 
migrating motor complex is associated with a raised basal pressure and 
may be a part of sphincter of Oddi dysfunction. 
210 
10.2 Future developments 
The most important development yet to be achieved is a safe method 
of prolonged possibly ambulatory manometry. At present pull-through 
techniques provide only a snap-shot of sphincter activity and are 
therefore far from ideal to diagnose sphincter of Oddi dysfunction a 
condition with characteristically causes intermittent symptoms . 
Prolonged manometry will not only provide more information about 
sphincter physiology, but will provide valuable information about 
sphincter of Oddi dysfunction, and may dismiss the dubious stigma with 
which this diagnosis is regarded. It is likely that mircotransducers rather 
than perfused catheters will be developed for prolonged manometry. 
The catheter will need a method of anchorage within the bile duct so 
that the recording device lies within the sphincter. A prototype has 
been developed for our own laboratory which has two mircotransducers 
mounted on a seven french catheter with a pigtail catheter at the distal 
end. There is a central channel which allows passage of a guidewire 
to straighten the pig-tail catheter for placement purposes. However this 
catheter has proved not only expensive to purchase but also in its 
upkeep due to its fragility. The size of the catheter also prevents its 
use in humans because of the theoretical risk of inducing pancreatitis 
due to obstruction of the pancreatic duct. Advances in microchip 
technology are likely to enable smaller and potentially safer catheters to 
be developed, it may even be possible to place a passive 
microtransducer onto a biliary stent and place this within the sphincter. 
However any object that distends the sphincter or allows free passage 
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of bile through the sphincter is unphysiological. It is important that 
suitable animal models such as the porcine model, are developed so 
that progress in catheter design and manometric methods can continue 
without putting patients or volunteers at risk. 
Advances in imaging techniques such as magnetic resonance imaging 
may provide acceptable non-invasive assessment of sphincter of Oddi 
function. To date no study has used this modality to assess sphincter 
function however with the development of magnetic resonant cholangio- 
pancreatography it does seem feasible and it may be possible to 
perform studies similar to the fatty meal, cholecystokinin or secretin 
ultrasound. Endoscopic ultrasound may also provide information about 
the sphincteric muscle. An interesting comparison would be to compare 
manometric assessment of sphincter of Oddi symmetry using the new 
nine lumen catheter with anatomical examination using endoscopic 
ultrasound. 
Psychological factors also need consideration as sphincter of Oddi 
dysfunction is often regarded as a functional disorder along with 
irritable bowel syndrome. Certainly both conditions have similarities, 
affecting young women who present with a diversity of symptoms. The 
closeness of these two conditions and their relationship to psychological 
parameters are currently part of a prospective study which although, 
instigated by me, is not yet complete and therefore not presented in 
this thesis. 
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Endoscopic sphincterotomy is the only proven technique for the 
treatment of sphincter of Oddi dysfunction. Botulinum toxin seems an 
attractive alternative and warrants formal clinical assessment. As a 
placebo- controlled trial is probably not ethical blinded comparison 
should by made with endoscopic sphincterotomy. Medical therapies at 
present are unsatisfactory but with the increased knowledge that 
prolonged ambulatory studies might provide, it is conceivable that non 
invasive treatments may yet prove clinically useful. 
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